<?xml version="1.0" encoding="UTF-8" standalone="yes"?><rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><generator>NFE/5.0</generator><title>"전임상" - Google 뉴스</title><link>https://news.google.com/search?pz=1&amp;cf=all&amp;hl=ko&amp;q=%EC%A0%84%EC%9E%84%EC%83%81&amp;cf=all&amp;gl=KR&amp;ceid=KR:ko</link><language>ko</language><webMaster>news-webmaster@google.com</webMaster><copyright>Copyright © 2026 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><lastBuildDate>Sun, 14 Jun 2026 07:55:03 GMT</lastBuildDate><image><title>Google 뉴스</title><url>https://lh3.googleusercontent.com/-DR60l-K8vnyi99NZovm9HlXyZwQ85GMDxiwJWzoasZYCUrPuUM_P_4Rb7ei03j-0nRs0c4F=w256</url><link>https://news.google.com/</link><height>256</height><width>256</width></image><description>Google 뉴스</description><item><title>올릭스 "혈뇌장벽 셔틀 결합체 전임상 데이터 얻어" - 뉴시스</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTE9kalhjR0JHcy04MkN4QjJiM3JvRGZtSG9mY2VTUVA4X1N5WVY1bjg1Q0NZemwtSFlUWWxObXBnWlRQeUNLSXN5QklHZ1h3amlvbW5LRmtZRTZIREtSckJiSdIBeEFVX3lxTE94OGNpN0c3bE13eVZ1Vkc5QWR3OU9aS25XQnM2ZE9KN3lTbHdZcEgybnZZWDdsWWpVVF9hMW5qUUwwLVVvUEVHZkwtcmdQeEtRcHJlLXVLMS10Vm1tZjUzOFZwSWg0bFlTZEdqc3hING1faGo0XzJmMw?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTE9kalhjR0JHcy04MkN4QjJiM3JvRGZtSG9mY2VTUVA4X1N5WVY1bjg1Q0NZemwtSFlUWWxObXBnWlRQeUNLSXN5QklHZ1h3amlvbW5LRmtZRTZIREtSckJiSdIBeEFVX3lxTE94OGNpN0c3bE13eVZ1Vkc5QWR3OU9aS25XQnM2ZE9KN3lTbHdZcEgybnZZWDdsWWpVVF9hMW5qUUwwLVVvUEVHZkwtcmdQeEtRcHJlLXVLMS10Vm1tZjUzOFZwSWg0bFlTZEdqc3hING1faGo0XzJmMw</guid><pubDate>Sun, 14 Jun 2026 00:01:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9kalhjR0JHcy04MkN4QjJiM3JvRGZtSG9mY2VTUVA4X1N5WVY1bjg1Q0NZemwtSFlUWWxObXBnWlRQeUNLSXN5QklHZ1h3amlvbW5LRmtZRTZIREtSckJiSdIBeEFVX3lxTE94OGNpN0c3bE13eVZ1Vkc5QWR3OU9aS25XQnM2ZE9KN3lTbHdZcEgybnZZWDdsWWpVVF9hMW5qUUwwLVVvUEVHZkwtcmdQeEtRcHJlLXVLMS10Vm1tZjUzOFZwSWg0bFlTZEdqc3hING1faGo0XzJmMw?oc=5" target="_blank"&gt;올릭스 "혈뇌장벽 셔틀 결합체 전임상 데이터 얻어"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴시스&lt;/font&gt;</description><source url="https://www.newsis.com">뉴시스</source></item><item><title>셀트리온, 항암 신약 후보 전임상 성과…임상 개발 속도 - 조선비즈 - Chosunbiz</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxQYmJQWDNCRVNSamhsa2pLVExOZ1hqck1zV3ZaclppY25rdVU2QXRtRDNlUGJFMXRVWlQyTnNfSGVYaUlHOHdpLWVfVUlBdDBZRVIwRkM1OEw5RmlCTksweEFxRWVrQ1dwUkRVLXJvbDBUbExPX0NBMXlJQzYtT3lvbUhYNGxiRFnSAZsBQVVfeXFMUFhnQlZMS0JmWXlLbzU4dElUcW5QanhzR1E1clZHSWxMSjludjUwcC1icnp0TlZsbnluWlN5TjdRNG8xOUtSekRpV2tTd2xzX2Q0el9Hd3FuUU1aZXNiUUxiQWphR3Q4ZlpTdGwtTmhPWWQ1STVad3EyeUtBSDNtTTFDa1ZPUWFFdC12ZG1zTm5scGxxRFhheU9EU1U?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxQYmJQWDNCRVNSamhsa2pLVExOZ1hqck1zV3ZaclppY25rdVU2QXRtRDNlUGJFMXRVWlQyTnNfSGVYaUlHOHdpLWVfVUlBdDBZRVIwRkM1OEw5RmlCTksweEFxRWVrQ1dwUkRVLXJvbDBUbExPX0NBMXlJQzYtT3lvbUhYNGxiRFnSAZsBQVVfeXFMUFhnQlZMS0JmWXlLbzU4dElUcW5QanhzR1E1clZHSWxMSjludjUwcC1icnp0TlZsbnluWlN5TjdRNG8xOUtSekRpV2tTd2xzX2Q0el9Hd3FuUU1aZXNiUUxiQWphR3Q4ZlpTdGwtTmhPWWQ1STVad3EyeUtBSDNtTTFDa1ZPUWFFdC12ZG1zTm5scGxxRFhheU9EU1U</guid><pubDate>Thu, 11 Jun 2026 23:52:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQYmJQWDNCRVNSamhsa2pLVExOZ1hqck1zV3ZaclppY25rdVU2QXRtRDNlUGJFMXRVWlQyTnNfSGVYaUlHOHdpLWVfVUlBdDBZRVIwRkM1OEw5RmlCTksweEFxRWVrQ1dwUkRVLXJvbDBUbExPX0NBMXlJQzYtT3lvbUhYNGxiRFnSAZsBQVVfeXFMUFhnQlZMS0JmWXlLbzU4dElUcW5QanhzR1E1clZHSWxMSjludjUwcC1icnp0TlZsbnluWlN5TjdRNG8xOUtSekRpV2tTd2xzX2Q0el9Hd3FuUU1aZXNiUUxiQWphR3Q4ZlpTdGwtTmhPWWQ1STVad3EyeUtBSDNtTTFDa1ZPUWFFdC12ZG1zTm5scGxxRFhheU9EU1U?oc=5" target="_blank"&gt;셀트리온, 항암 신약 후보 전임상 성과…임상 개발 속도 - 조선비즈&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Chosunbiz&lt;/font&gt;</description><source url="https://biz.chosun.com">Chosunbiz</source></item><item><title>셀트리온, HER2 이중특이항체 전임상 성과 공개 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFBhX1llV2hVXzFBSTQyYmNGbEtSNWdJSnhDS1AyMGJkNmN4QnNsQ3lKeXAwSUFiTFJ3R3lhSXozcmYxOVFpVXJHMHlzRXFaa0JzTUNCdmQyUVJRc3RNVEhQczg5MVJxRVQ0YWxFYg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFBhX1llV2hVXzFBSTQyYmNGbEtSNWdJSnhDS1AyMGJkNmN4QnNsQ3lKeXAwSUFiTFJ3R3lhSXozcmYxOVFpVXJHMHlzRXFaa0JzTUNCdmQyUVJRc3RNVEhQczg5MVJxRVQ0YWxFYg</guid><pubDate>Fri, 12 Jun 2026 00:51:10 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFBhX1llV2hVXzFBSTQyYmNGbEtSNWdJSnhDS1AyMGJkNmN4QnNsQ3lKeXAwSUFiTFJ3R3lhSXozcmYxOVFpVXJHMHlzRXFaa0JzTUNCdmQyUVJRc3RNVEhQczg5MVJxRVQ0YWxFYg?oc=5" target="_blank"&gt;셀트리온, HER2 이중특이항체 전임상 성과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>올릭스, "BBB셔틀 적용 TfR 타깃 siRNA 전임상 성과 확보" - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5HNUlRRkxURm5MUnd5MXhET3ZvOE1CNjVQQTVqUldJb1BVYWZyaHRFOTd3V1ROb1VFS3lJT1VFa0dqcERtNUw5Y2d4d2QwRkxpVU9JbzY1a2FEX19GdjhjdUZITXlXS1NsMWs0?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5HNUlRRkxURm5MUnd5MXhET3ZvOE1CNjVQQTVqUldJb1BVYWZyaHRFOTd3V1ROb1VFS3lJT1VFa0dqcERtNUw5Y2d4d2QwRkxpVU9JbzY1a2FEX19GdjhjdUZITXlXS1NsMWs0</guid><pubDate>Fri, 12 Jun 2026 05:03:40 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5HNUlRRkxURm5MUnd5MXhET3ZvOE1CNjVQQTVqUldJb1BVYWZyaHRFOTd3V1ROb1VFS3lJT1VFa0dqcERtNUw5Y2d4d2QwRkxpVU9JbzY1a2FEX19GdjhjdUZITXlXS1NsMWs0?oc=5" target="_blank"&gt;올릭스, "BBB셔틀 적용 TfR 타깃 siRNA 전임상 성과 확보"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>셀트리온 다중항체 신약, 전임상서 항암 효능·내약성 확인 - 뉴스토마토</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTFBMLTFjLTlYZU9lckZXaHVaSUlLZk1iM0NDV0p5RFJOQ0FUbHVDRTBsNnRYalVyM3BiY2djV1FLZXl2Y1pfT1FBV25uck52eHZtbkhKU253emE0bGNaTjRpUA?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTFBMLTFjLTlYZU9lckZXaHVaSUlLZk1iM0NDV0p5RFJOQ0FUbHVDRTBsNnRYalVyM3BiY2djV1FLZXl2Y1pfT1FBV25uck52eHZtbkhKU253emE0bGNaTjRpUA</guid><pubDate>Fri, 12 Jun 2026 00:58:09 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBMLTFjLTlYZU9lckZXaHVaSUlLZk1iM0NDV0p5RFJOQ0FUbHVDRTBsNnRYalVyM3BiY2djV1FLZXl2Y1pfT1FBV25uck52eHZtbkhKU253emE0bGNaTjRpUA?oc=5" target="_blank"&gt;셀트리온 다중항체 신약, 전임상서 항암 효능·내약성 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스토마토&lt;/font&gt;</description><source url="https://www.newstomato.com">뉴스토마토</source></item><item><title>올릭스, 벡트-호러스 BBB 셔틀 적용 TfR 타깃 siRNA 전임상 성과 확보 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5hZklLVmtVaGdMS1RwaUhBbVZHYkpjY2hmR0ZNWGFVdi11b3VpX2l2YVFBbGpUc0YteXN4VndiZUhGS2pfdWlnMnFBQlUxQ3BjRXB0MVQxa1VuS21fM09jUlVneUswb3pXUTJ3NtIBcEFVX3lxTE9mdzkwX2NqYnpjR0wxcGJfbEVKWFIyS192Tm1KRS1IWWNSLWE0Z3dNUXM0MlFYTnhRa3JBMkFYUVFBdDc0RkhBb3puZGIybHo3LVA2VmlQN3llTEdBX3VaVG9WM21wYlgwQnQxaGNCZDI?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5hZklLVmtVaGdMS1RwaUhBbVZHYkpjY2hmR0ZNWGFVdi11b3VpX2l2YVFBbGpUc0YteXN4VndiZUhGS2pfdWlnMnFBQlUxQ3BjRXB0MVQxa1VuS21fM09jUlVneUswb3pXUTJ3NtIBcEFVX3lxTE9mdzkwX2NqYnpjR0wxcGJfbEVKWFIyS192Tm1KRS1IWWNSLWE0Z3dNUXM0MlFYTnhRa3JBMkFYUVFBdDc0RkhBb3puZGIybHo3LVA2VmlQN3llTEdBX3VaVG9WM21wYlgwQnQxaGNCZDI</guid><pubDate>Fri, 12 Jun 2026 04:46:27 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5hZklLVmtVaGdMS1RwaUhBbVZHYkpjY2hmR0ZNWGFVdi11b3VpX2l2YVFBbGpUc0YteXN4VndiZUhGS2pfdWlnMnFBQlUxQ3BjRXB0MVQxa1VuS21fM09jUlVneUswb3pXUTJ3NtIBcEFVX3lxTE9mdzkwX2NqYnpjR0wxcGJfbEVKWFIyS192Tm1KRS1IWWNSLWE0Z3dNUXM0MlFYTnhRa3JBMkFYUVFBdDc0RkhBb3puZGIybHo3LVA2VmlQN3llTEdBX3VaVG9WM21wYlgwQnQxaGNCZDI?oc=5" target="_blank"&gt;올릭스, 벡트-호러스 BBB 셔틀 적용 TfR 타깃 siRNA 전임상 성과 확보&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>셀트리온, 다중항체 항암 신약 전임상 성과…엔허투 한계 넘을까 - 조세일보</title><link>https://news.google.com/rss/articles/CBMiX0FVX3lxTE4tWnRjNV9LR0hlWHVETWNMaFFFbldPcFp2Y05LTVg4V0M4STVyNUhDemFmNWE0VmVFbFljLUFDVk5oLTYweXd0dFZMSHYxZjkxTFphMUNqV2UxSFdWOTZJ?oc=5</link><guid isPermaLink="false">CBMiX0FVX3lxTE4tWnRjNV9LR0hlWHVETWNMaFFFbldPcFp2Y05LTVg4V0M4STVyNUhDemFmNWE0VmVFbFljLUFDVk5oLTYweXd0dFZMSHYxZjkxTFphMUNqV2UxSFdWOTZJ</guid><pubDate>Fri, 12 Jun 2026 07:41:38 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE4tWnRjNV9LR0hlWHVETWNMaFFFbldPcFp2Y05LTVg4V0M4STVyNUhDemFmNWE0VmVFbFljLUFDVk5oLTYweXd0dFZMSHYxZjkxTFphMUNqV2UxSFdWOTZJ?oc=5" target="_blank"&gt;셀트리온, 다중항체 항암 신약 전임상 성과…엔허투 한계 넘을까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;조세일보&lt;/font&gt;</description><source url="https://m.joseilbo.com">조세일보</source></item><item><title>올릭스 "벡트-호러스 플랫폼 적용 siRNA 전임상서 성과 확보" - v.daum.net</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE9CU2NFRnVEYm56bzF5VTN2a1pyUjNvQnh2dkllS0RCcnhoUDdJcXBZMjFqc3RrdWVGRDZuZHVnVHFsZGljS1daTlVkX2lTMnM?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE9CU2NFRnVEYm56bzF5VTN2a1pyUjNvQnh2dkllS0RCcnhoUDdJcXBZMjFqc3RrdWVGRDZuZHVnVHFsZGljS1daTlVkX2lTMnM</guid><pubDate>Fri, 12 Jun 2026 04:49:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE9CU2NFRnVEYm56bzF5VTN2a1pyUjNvQnh2dkllS0RCcnhoUDdJcXBZMjFqc3RrdWVGRDZuZHVnVHFsZGljS1daTlVkX2lTMnM?oc=5" target="_blank"&gt;올릭스 "벡트-호러스 플랫폼 적용 siRNA 전임상서 성과 확보"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;v.daum.net&lt;/font&gt;</description><source url="https://v.daum.net">v.daum.net</source></item><item><title>알테오젠, 'SC제형' ADC 전임상 "피부·혈액지표 개선" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE1jeExTR2h5dDlDaWJWZklvWGVIRVBOSkVGYzdWNE1CbEZnbGFJdVY0MlpOVnBWdzBjQnlOOVRybUJJUFM1TkxUSGhvbjE1Njl1bjVIdjB1RQ?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE1jeExTR2h5dDlDaWJWZklvWGVIRVBOSkVGYzdWNE1CbEZnbGFJdVY0MlpOVnBWdzBjQnlOOVRybUJJUFM1TkxUSGhvbjE1Njl1bjVIdjB1RQ</guid><pubDate>Wed, 10 Jun 2026 06:23:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE1jeExTR2h5dDlDaWJWZklvWGVIRVBOSkVGYzdWNE1CbEZnbGFJdVY0MlpOVnBWdzBjQnlOOVRybUJJUFM1TkxUSGhvbjE1Njl1bjVIdjB1RQ?oc=5" target="_blank"&gt;알테오젠, 'SC제형' ADC 전임상 "피부·혈액지표 개선"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>[임상 업데이트] 올릭스, TfR 타깃 siRNA 전임상 성과 확보 - 이데일리</title><link>https://news.google.com/rss/articles/CBMigAFBVV95cUxQTjFRNndUb2NzZ0hjZDIxOUR0OWxpcjFMb1oxRXdCbW0tQm5YNTlzdDE1aWJLWnRnUVFJVk9RVUtSRE9id29VSTBMbXAzb1NNY0dHYUtsYlZDTjZycnZoZGpad19adkdlTk9aREdkWGgyaHdFVzlpVU9oTHZBVjgzVg?oc=5</link><guid isPermaLink="false">CBMigAFBVV95cUxQTjFRNndUb2NzZ0hjZDIxOUR0OWxpcjFMb1oxRXdCbW0tQm5YNTlzdDE1aWJLWnRnUVFJVk9RVUtSRE9id29VSTBMbXAzb1NNY0dHYUtsYlZDTjZycnZoZGpad19adkdlTk9aREdkWGgyaHdFVzlpVU9oTHZBVjgzVg</guid><pubDate>Fri, 12 Jun 2026 22:01:02 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxQTjFRNndUb2NzZ0hjZDIxOUR0OWxpcjFMb1oxRXdCbW0tQm5YNTlzdDE1aWJLWnRnUVFJVk9RVUtSRE9id29VSTBMbXAzb1NNY0dHYUtsYlZDTjZycnZoZGpad19adkdlTk9aREdkWGgyaHdFVzlpVU9oTHZBVjgzVg?oc=5" target="_blank"&gt;[임상 업데이트] 올릭스, TfR 타깃 siRNA 전임상 성과 확보&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;이데일리&lt;/font&gt;</description><source url="https://www.edaily.co.kr">이데일리</source></item><item><title>삼성바이오에피스, AACR서 ‘1호 개발 신약’ 전임상 결과 공개 - 쿠키뉴스</title><link>https://news.google.com/rss/articles/CBMiY0FVX3lxTFBtMExsMXBoQmJhSzItT0ZvM1d5UVI1QXVRV2VlalF1aGFVVnlBZEsxMEcwb3JDeEpidXNPVm4zblRYZk5mM0ktcFpKeHhUYk1JMms0WXhSdFp1TkttMU1MV3N5UQ?oc=5</link><guid isPermaLink="false">CBMiY0FVX3lxTFBtMExsMXBoQmJhSzItT0ZvM1d5UVI1QXVRV2VlalF1aGFVVnlBZEsxMEcwb3JDeEpidXNPVm4zblRYZk5mM0ktcFpKeHhUYk1JMms0WXhSdFp1TkttMU1MV3N5UQ</guid><pubDate>Wed, 10 Jun 2026 20:52:24 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTFBtMExsMXBoQmJhSzItT0ZvM1d5UVI1QXVRV2VlalF1aGFVVnlBZEsxMEcwb3JDeEpidXNPVm4zblRYZk5mM0ktcFpKeHhUYk1JMms0WXhSdFp1TkttMU1MV3N5UQ?oc=5" target="_blank"&gt;삼성바이오에피스, AACR서 ‘1호 개발 신약’ 전임상 결과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;쿠키뉴스&lt;/font&gt;</description><source url="https://www.kukinews.com">쿠키뉴스</source></item><item><title>셀트리온, HER2 타깃 T세포 인게이저 전임상 연구 결과 "학회서 발표" - 파이낸스스코프</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE9nc1FQMTNUVC1HUXN6WTFFeThEWk12OThjRTRnU0IxMkNteWw4VGxoLWdPb0F1aVNaTGRHQS0wQmcxbTI3cmdoNThzRkswWF9tNURDLVl3ZDNtYV96NENqRmZ1eGdCX3dEakE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE9nc1FQMTNUVC1HUXN6WTFFeThEWk12OThjRTRnU0IxMkNteWw4VGxoLWdPb0F1aVNaTGRHQS0wQmcxbTI3cmdoNThzRkswWF9tNURDLVl3ZDNtYV96NENqRmZ1eGdCX3dEakE</guid><pubDate>Thu, 11 Jun 2026 23:25:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9nc1FQMTNUVC1HUXN6WTFFeThEWk12OThjRTRnU0IxMkNteWw4VGxoLWdPb0F1aVNaTGRHQS0wQmcxbTI3cmdoNThzRkswWF9tNURDLVl3ZDNtYV96NENqRmZ1eGdCX3dEakE?oc=5" target="_blank"&gt;셀트리온, HER2 타깃 T세포 인게이저 전임상 연구 결과 "학회서 발표"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;파이낸스스코프&lt;/font&gt;</description><source url="https://www.finance-scope.com">파이낸스스코프</source></item><item><title>J&amp;J, 왜 전임상 DAC 플랫폼에 1.5조 원 베팅했나…빅파마 M&amp;A의 새 공식 읽힌다 - 바이오타임즈</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5pVUpSclRySDgwOU1YS05QOXN1MDU3LThnTk9RS0x1OFJRV0VVQkRfR2VmaHU1NXdYSTFnenBRdy1sbndJZVFLZm43T0lGY0tuc3RaTlNNNDFyLTlhS0pYZWlHNE5BelZvWTBVTg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5pVUpSclRySDgwOU1YS05QOXN1MDU3LThnTk9RS0x1OFJRV0VVQkRfR2VmaHU1NXdYSTFnenBRdy1sbndJZVFLZm43T0lGY0tuc3RaTlNNNDFyLTlhS0pYZWlHNE5BelZvWTBVTg</guid><pubDate>Tue, 09 Jun 2026 09:17:59 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5pVUpSclRySDgwOU1YS05QOXN1MDU3LThnTk9RS0x1OFJRV0VVQkRfR2VmaHU1NXdYSTFnenBRdy1sbndJZVFLZm43T0lGY0tuc3RaTlNNNDFyLTlhS0pYZWlHNE5BelZvWTBVTg?oc=5" target="_blank"&gt;J&amp;J, 왜 전임상 DAC 플랫폼에 1.5조 원 베팅했나…빅파마 M&amp;A의 새 공식 읽힌다&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오타임즈&lt;/font&gt;</description><source url="https://www.biotimes.co.kr">바이오타임즈</source></item><item><title>지놈앤컴퍼니, '전임상 기술이전'으로 글로벌 빅딜 문턱 넘을까 - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE43b0Y0MzJkaFNXbDk1SGttU09XYzNFaWRRU2VhSC1fci1EWndmMHpMeWFCb0ktckVzMXhoYXlYNVI2TEhCeFpnRkhHT05HalJuOXBid283WGJ3VHhvY0hvU1g5RjlSUnlQRXpjY29ja9IBc0FVX3lxTE51bDJ2Y2NGWU1KRmxFZ0pvWHlPdVR6NnhYYmRobTBiSzVXaThsRU1WR1ZKQTZMbzlqODljTy1CS2dJd0otVEV6RzdOelJ4SXJCYnl0R2diZ3Z0X1BEWDE2WjA0YUx5YlFUaUdxMGpTLXJXU2s?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE43b0Y0MzJkaFNXbDk1SGttU09XYzNFaWRRU2VhSC1fci1EWndmMHpMeWFCb0ktckVzMXhoYXlYNVI2TEhCeFpnRkhHT05HalJuOXBid283WGJ3VHhvY0hvU1g5RjlSUnlQRXpjY29ja9IBc0FVX3lxTE51bDJ2Y2NGWU1KRmxFZ0pvWHlPdVR6NnhYYmRobTBiSzVXaThsRU1WR1ZKQTZMbzlqODljTy1CS2dJd0otVEV6RzdOelJ4SXJCYnl0R2diZ3Z0X1BEWDE2WjA0YUx5YlFUaUdxMGpTLXJXU2s</guid><pubDate>Tue, 09 Jun 2026 06:48:41 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE43b0Y0MzJkaFNXbDk1SGttU09XYzNFaWRRU2VhSC1fci1EWndmMHpMeWFCb0ktckVzMXhoYXlYNVI2TEhCeFpnRkhHT05HalJuOXBid283WGJ3VHhvY0hvU1g5RjlSUnlQRXpjY29ja9IBc0FVX3lxTE51bDJ2Y2NGWU1KRmxFZ0pvWHlPdVR6NnhYYmRobTBiSzVXaThsRU1WR1ZKQTZMbzlqODljTy1CS2dJd0otVEV6RzdOelJ4SXJCYnl0R2diZ3Z0X1BEWDE2WjA0YUx5YlFUaUdxMGpTLXJXU2s?oc=5" target="_blank"&gt;지놈앤컴퍼니, '전임상 기술이전'으로 글로벌 빅딜 문턱 넘을까&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>알테오젠, 'ADC 피하주사' 전임상서 독성 개선·흡수 개선 확인 - 머니투데이 - 머니투데이</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE9wWU9hRGVDV2NZMWI1QW54VXczam9vMFhZYmZrYVNMdjg0THQ2UDhYUjlOWVh6ME54bjBBLURGdV9KMjA0eTZzM0JVb2E3cU02R0F4MHByRkU5NFlCRXVGQ3p4dVBoalV1ZmfSAW9BVV95cUxPYnZHZmUzTThWWlJMUGQySkJfS1FldXRHNDBaYzJhdGJlbEZiNUpsWnFQOU5CeVRvNGFEOGhzYlFQLWZmUzltbzlLSWU4cnlMZk9LaERqMVk0WXltS09qU0NHQ2prUHAwaE5qbnd3eEE?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE9wWU9hRGVDV2NZMWI1QW54VXczam9vMFhZYmZrYVNMdjg0THQ2UDhYUjlOWVh6ME54bjBBLURGdV9KMjA0eTZzM0JVb2E3cU02R0F4MHByRkU5NFlCRXVGQ3p4dVBoalV1ZmfSAW9BVV95cUxPYnZHZmUzTThWWlJMUGQySkJfS1FldXRHNDBaYzJhdGJlbEZiNUpsWnFQOU5CeVRvNGFEOGhzYlFQLWZmUzltbzlLSWU4cnlMZk9LaERqMVk0WXltS09qU0NHQ2prUHAwaE5qbnd3eEE</guid><pubDate>Wed, 10 Jun 2026 09:11:39 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE9wWU9hRGVDV2NZMWI1QW54VXczam9vMFhZYmZrYVNMdjg0THQ2UDhYUjlOWVh6ME54bjBBLURGdV9KMjA0eTZzM0JVb2E3cU02R0F4MHByRkU5NFlCRXVGQ3p4dVBoalV1ZmfSAW9BVV95cUxPYnZHZmUzTThWWlJMUGQySkJfS1FldXRHNDBaYzJhdGJlbEZiNUpsWnFQOU5CeVRvNGFEOGhzYlFQLWZmUzltbzlLSWU4cnlMZk9LaERqMVk0WXltS09qU0NHQ2prUHAwaE5qbnd3eEE?oc=5" target="_blank"&gt;알테오젠, 'ADC 피하주사' 전임상서 독성 개선·흡수 개선 확인 - 머니투데이&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;머니투데이&lt;/font&gt;</description><source url="https://www.mt.co.kr">머니투데이</source></item><item><title>JW중외제약 “전임상서 희소 신경발달장애 신약 효능 확인” - 조선비즈 - Chosunbiz</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxOX3c4T0RiLURMZVhHNGNSSGlWWTB0WWlTUmtTczlhMXhsV0ZmbVBBT0hDd0tiR1I2WXZLMmhKSHdWY3lMTWRQZVZ5WHZ1QXRKR05jNHVTRGxGUnhiYTFndTZuREV0ZUNRdE5kYUJSWUU3STVrdEh4d2NJTEx0MTJtdnFCa2NOTWPSAZsBQVVfeXFMTlhHR0ZaN0twSENfZlV3TW9BWm5VMlU5QWQwc0V0T2tvbmtQNGlJU3lYWFRMVmdBU2hoVTg4NzdBdlR0MEN6MXo2OHJ1QnBKZFZzM3NYOWZXRGpFMWZqQmdpWlpCOHNoUFNVTlVEODhzR1JjMXZYQXNzRjVpS2ZMbml3RHpjNTlkQmJUNElRSWY2ckpvRlc4WkZ3R0E?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxOX3c4T0RiLURMZVhHNGNSSGlWWTB0WWlTUmtTczlhMXhsV0ZmbVBBT0hDd0tiR1I2WXZLMmhKSHdWY3lMTWRQZVZ5WHZ1QXRKR05jNHVTRGxGUnhiYTFndTZuREV0ZUNRdE5kYUJSWUU3STVrdEh4d2NJTEx0MTJtdnFCa2NOTWPSAZsBQVVfeXFMTlhHR0ZaN0twSENfZlV3TW9BWm5VMlU5QWQwc0V0T2tvbmtQNGlJU3lYWFRMVmdBU2hoVTg4NzdBdlR0MEN6MXo2OHJ1QnBKZFZzM3NYOWZXRGpFMWZqQmdpWlpCOHNoUFNVTlVEODhzR1JjMXZYQXNzRjVpS2ZMbml3RHpjNTlkQmJUNElRSWY2ckpvRlc4WkZ3R0E</guid><pubDate>Thu, 11 Jun 2026 08:50:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxOX3c4T0RiLURMZVhHNGNSSGlWWTB0WWlTUmtTczlhMXhsV0ZmbVBBT0hDd0tiR1I2WXZLMmhKSHdWY3lMTWRQZVZ5WHZ1QXRKR05jNHVTRGxGUnhiYTFndTZuREV0ZUNRdE5kYUJSWUU3STVrdEh4d2NJTEx0MTJtdnFCa2NOTWPSAZsBQVVfeXFMTlhHR0ZaN0twSENfZlV3TW9BWm5VMlU5QWQwc0V0T2tvbmtQNGlJU3lYWFRMVmdBU2hoVTg4NzdBdlR0MEN6MXo2OHJ1QnBKZFZzM3NYOWZXRGpFMWZqQmdpWlpCOHNoUFNVTlVEODhzR1JjMXZYQXNzRjVpS2ZMbml3RHpjNTlkQmJUNElRSWY2ckpvRlc4WkZ3R0E?oc=5" target="_blank"&gt;JW중외제약 “전임상서 희소 신경발달장애 신약 효능 확인” - 조선비즈&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Chosunbiz&lt;/font&gt;</description><source url="https://biz.chosun.com">Chosunbiz</source></item><item><title>알테오젠, 월드ADC서 ALT-B4 기반 ADC 피하주사 전임상 결과 공개 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE1iY2VxUTFILTV2SHdIaHo5cWxSU1B4YzJGZEVfVUJLWHhFV2FSWDZ3NTZUem1NUlJ4Y1JkUTQwMTRvR3NvdnM5SWF0NnNmdGVQZmp6c3pTUWp3R1FqcmpzR1JXXzNHWlJndnZzdlF3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE1iY2VxUTFILTV2SHdIaHo5cWxSU1B4YzJGZEVfVUJLWHhFV2FSWDZ3NTZUem1NUlJ4Y1JkUTQwMTRvR3NvdnM5SWF0NnNmdGVQZmp6c3pTUWp3R1FqcmpzR1JXXzNHWlJndnZzdlF3</guid><pubDate>Wed, 10 Jun 2026 04:57:13 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1iY2VxUTFILTV2SHdIaHo5cWxSU1B4YzJGZEVfVUJLWHhFV2FSWDZ3NTZUem1NUlJ4Y1JkUTQwMTRvR3NvdnM5SWF0NnNmdGVQZmp6c3pTUWp3R1FqcmpzR1JXXzNHWlJndnZzdlF3?oc=5" target="_blank"&gt;알테오젠, 월드ADC서 ALT-B4 기반 ADC 피하주사 전임상 결과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>올릭스-벡트-호러스, BBB 셔틀 적용 siRNA 전임상 "표적 유전자 억제" - 파이낸스스코프</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5Oc2hFMDljZ2FzSEdaWVhSejdOOGJrVEdLcHhVUnpfTDRVcTdsTXJYZjFPcWxBR2NHZlAtSXIxMG9Bb0phY0NRU192NHRLcTF3SnNoT2VZLTZVaDdWT0gwZVlKWEFYcjRhV0E?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5Oc2hFMDljZ2FzSEdaWVhSejdOOGJrVEdLcHhVUnpfTDRVcTdsTXJYZjFPcWxBR2NHZlAtSXIxMG9Bb0phY0NRU192NHRLcTF3SnNoT2VZLTZVaDdWT0gwZVlKWEFYcjRhV0E</guid><pubDate>Fri, 12 Jun 2026 05:12:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5Oc2hFMDljZ2FzSEdaWVhSejdOOGJrVEdLcHhVUnpfTDRVcTdsTXJYZjFPcWxBR2NHZlAtSXIxMG9Bb0phY0NRU192NHRLcTF3SnNoT2VZLTZVaDdWT0gwZVlKWEFYcjRhV0E?oc=5" target="_blank"&gt;올릭스-벡트-호러스, BBB 셔틀 적용 siRNA 전임상 "표적 유전자 억제"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;파이낸스스코프&lt;/font&gt;</description><source url="https://www.finance-scope.com">파이낸스스코프</source></item><item><title>바이젠셀, 유럽암학회서 교모세포종 항암 신약 전임상 결과 발표 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE14QzJGMkJoSlhacjRmdGZjREpyOER4UTJMRWxwOUZRQUoyelBqdGd3YTNlNUNfWjdMUFRJY05DYUdSbXg1UjVWOGpUeVk5UWpTOF9oNlZmR0dZWjl4YXpGWTBFSWNTY2JtUzZR?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE14QzJGMkJoSlhacjRmdGZjREpyOER4UTJMRWxwOUZRQUoyelBqdGd3YTNlNUNfWjdMUFRJY05DYUdSbXg1UjVWOGpUeVk5UWpTOF9oNlZmR0dZWjl4YXpGWTBFSWNTY2JtUzZR</guid><pubDate>Mon, 08 Jun 2026 01:13:13 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE14QzJGMkJoSlhacjRmdGZjREpyOER4UTJMRWxwOUZRQUoyelBqdGd3YTNlNUNfWjdMUFRJY05DYUdSbXg1UjVWOGpUeVk5UWpTOF9oNlZmR0dZWjl4YXpGWTBFSWNTY2JtUzZR?oc=5" target="_blank"&gt;바이젠셀, 유럽암학회서 교모세포종 항암 신약 전임상 결과 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>바이젠셀, 유럽암학회서 교모세포종 신약 ‘VC302’ 전임상 결과 공개 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE1xSXZJcktMRzBKRmRsWWgxVnpEa3pNOVBzcFNoejRwY3lUWXYxa25ObDhWWUFTYTBSMjE4aWwzdExxeGNOd3hubWwyM2RadEx5aFZaMzhGbHhfbDYxaHRnQkhod18zSG5yQnVPNUh3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE1xSXZJcktMRzBKRmRsWWgxVnpEa3pNOVBzcFNoejRwY3lUWXYxa25ObDhWWUFTYTBSMjE4aWwzdExxeGNOd3hubWwyM2RadEx5aFZaMzhGbHhfbDYxaHRnQkhod18zSG5yQnVPNUh3</guid><pubDate>Mon, 08 Jun 2026 00:38:38 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE1xSXZJcktMRzBKRmRsWWgxVnpEa3pNOVBzcFNoejRwY3lUWXYxa25ObDhWWUFTYTBSMjE4aWwzdExxeGNOd3hubWwyM2RadEx5aFZaMzhGbHhfbDYxaHRnQkhod18zSG5yQnVPNUh3?oc=5" target="_blank"&gt;바이젠셀, 유럽암학회서 교모세포종 신약 ‘VC302’ 전임상 결과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>[제약·바이오 레이더] 셀트리온, 다중항체 신약 전임상서 항암 효과·내약성 확인 - 더밸류뉴스</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE1ObFVuZXlhU3NVZk44TkN2d1pQSC1CbnZCVmt5blk5eUlFc29abWlld3RPUlBYUGtKelNIaFVsNXlQbXhUUlhmOFNnM0Zmd0lfM0xwdg?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE1ObFVuZXlhU3NVZk44TkN2d1pQSC1CbnZCVmt5blk5eUlFc29abWlld3RPUlBYUGtKelNIaFVsNXlQbXhUUlhmOFNnM0Zmd0lfM0xwdg</guid><pubDate>Fri, 12 Jun 2026 04:46:21 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE1ObFVuZXlhU3NVZk44TkN2d1pQSC1CbnZCVmt5blk5eUlFc29abWlld3RPUlBYUGtKelNIaFVsNXlQbXhUUlhmOFNnM0Zmd0lfM0xwdg?oc=5" target="_blank"&gt;[제약·바이오 레이더] 셀트리온, 다중항체 신약 전임상서 항암 효과·내약성 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더밸류뉴스&lt;/font&gt;</description><source url="https://www.thevaluenews.co.kr">더밸류뉴스</source></item><item><title>[BioS]셀트리온, ‘HER2xCD3 TCE' 전임상 중간결과 "발표" - 이투데이</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE1xay1mTURFNlVpTFpLNHlUdlg4WWhCbDBnOHNOLVNLbUp1cC1wWHdMamdCRV9KbUNmLXRFd2hQc2RCNU8zV3lRTm95MVRYZGhYM1hpVw?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE1xay1mTURFNlVpTFpLNHlUdlg4WWhCbDBnOHNOLVNLbUp1cC1wWHdMamdCRV9KbUNmLXRFd2hQc2RCNU8zV3lRTm95MVRYZGhYM1hpVw</guid><pubDate>Fri, 12 Jun 2026 07:02:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE1xay1mTURFNlVpTFpLNHlUdlg4WWhCbDBnOHNOLVNLbUp1cC1wWHdMamdCRV9KbUNmLXRFd2hQc2RCNU8zV3lRTm95MVRYZGhYM1hpVw?oc=5" target="_blank"&gt;[BioS]셀트리온, ‘HER2xCD3 TCE' 전임상 중간결과 "발표"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;이투데이&lt;/font&gt;</description><source url="https://www.etoday.co.kr">이투데이</source></item><item><title>셀트리온, 다중항체 항암제 'CT-P72' 전임상 성과 공개 - ebn.co.kr</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE9KRGhZSU82TTVlb3YxNHVOZWZFTjVzQnRCaEZvcGxua21sdDlHUzdTczc2c2UyWWhWeS1nMjNEMUFvWEJMSFFOdXAyTUVQZmEtUnBNWnVwbkt0OTU3RFg1TGVWUUIzbGll?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE9KRGhZSU82TTVlb3YxNHVOZWZFTjVzQnRCaEZvcGxua21sdDlHUzdTczc2c2UyWWhWeS1nMjNEMUFvWEJMSFFOdXAyTUVQZmEtUnBNWnVwbkt0OTU3RFg1TGVWUUIzbGll</guid><pubDate>Fri, 12 Jun 2026 05:43:03 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE9KRGhZSU82TTVlb3YxNHVOZWZFTjVzQnRCaEZvcGxua21sdDlHUzdTczc2c2UyWWhWeS1nMjNEMUFvWEJMSFFOdXAyTUVQZmEtUnBNWnVwbkt0OTU3RFg1TGVWUUIzbGll?oc=5" target="_blank"&gt;셀트리온, 다중항체 항암제 'CT-P72' 전임상 성과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;ebn.co.kr&lt;/font&gt;</description><source url="https://www.ebn.co.kr">ebn.co.kr</source></item><item><title>프로티나,차세대 비만 치료제 전임상 데이터 공개... “요요 현상 방지” - 약업신문</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE9fUVJCZTlNTlEzaER2S2s0cWNCWFR0ekFsVFZSSk9XUnZmTkZEaUwwNUpVN3FEcDdXejJPWHhnRldvTjJUTkRVTWxqZ25jZEhQNkZ5M0FLYmxMWWxldEx1QUpSM3FZZw?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE9fUVJCZTlNTlEzaER2S2s0cWNCWFR0ekFsVFZSSk9XUnZmTkZEaUwwNUpVN3FEcDdXejJPWHhnRldvTjJUTkRVTWxqZ25jZEhQNkZ5M0FLYmxMWWxldEx1QUpSM3FZZw</guid><pubDate>Tue, 09 Jun 2026 01:02:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE9fUVJCZTlNTlEzaER2S2s0cWNCWFR0ekFsVFZSSk9XUnZmTkZEaUwwNUpVN3FEcDdXejJPWHhnRldvTjJUTkRVTWxqZ25jZEhQNkZ5M0FLYmxMWWxldEx1QUpSM3FZZw?oc=5" target="_blank"&gt;프로티나,차세대 비만 치료제 전임상 데이터 공개... “요요 현상 방지”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약업신문&lt;/font&gt;</description><source url="http://m.yakup.com">약업신문</source></item><item><title>바이젠셀, 'GD2 CAR-NK' GBM 전임상 "EACR 발표" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE93MmFmazJpRjJmOFdtZ2pxWWJad0J2MUx1NFA5RkZST0NhNUZCUDBYRkxJemJGT3pBcDVLNXFzZ2tRWmoxU1l0T0oxeFJVeGNMdVJibktmOA?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE93MmFmazJpRjJmOFdtZ2pxWWJad0J2MUx1NFA5RkZST0NhNUZCUDBYRkxJemJGT3pBcDVLNXFzZ2tRWmoxU1l0T0oxeFJVeGNMdVJibktmOA</guid><pubDate>Mon, 08 Jun 2026 08:05:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE93MmFmazJpRjJmOFdtZ2pxWWJad0J2MUx1NFA5RkZST0NhNUZCUDBYRkxJemJGT3pBcDVLNXFzZ2tRWmoxU1l0T0oxeFJVeGNMdVJibktmOA?oc=5" target="_blank"&gt;바이젠셀, 'GD2 CAR-NK' GBM 전임상 "EACR 발표"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>대원제약, ADA서 '4중 비만 작용제' 전임상 첫 공개 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9TekFzeFNieklPRkpsZ1VnQ0dOaFhnbHNObzd3VzU3bTlmalZYdFpmSjAxV2QtQUdWVEx3Wl9ZMnpvT0QxNlJzcDJ1cjNRMTN2SDRvNkdrQmd4b05HbGhPSnB3cDJPcjFTS1VN?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9TekFzeFNieklPRkpsZ1VnQ0dOaFhnbHNObzd3VzU3bTlmalZYdFpmSjAxV2QtQUdWVEx3Wl9ZMnpvT0QxNlJzcDJ1cjNRMTN2SDRvNkdrQmd4b05HbGhPSnB3cDJPcjFTS1VN</guid><pubDate>Fri, 05 Jun 2026 08:47:32 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9TekFzeFNieklPRkpsZ1VnQ0dOaFhnbHNObzd3VzU3bTlmalZYdFpmSjAxV2QtQUdWVEx3Wl9ZMnpvT0QxNlJzcDJ1cjNRMTN2SDRvNkdrQmd4b05HbGhPSnB3cDJPcjFTS1VN?oc=5" target="_blank"&gt;대원제약, ADA서 '4중 비만 작용제' 전임상 첫 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>알테오젠, ADC 적용 피하주사 제형화 전임상 결과 공개 - 서울경제</title><link>https://news.google.com/rss/articles/CBMiUkFVX3lxTFBaNUxvN0U2ckZob0tjc3Y2dWYxUGExUHNiWW1yaU93N1BNUHlTUll0SFNJMVBKemkwYndWcjBSWVNtQ1ZROXI0YTBNYUJWTlgza1HSAVNBVV95cUxNMWgwMm5pUlVKbHIxZVFmcExOQUkwSkI0UFBrSFU3XzZDMnNhT3ZIbWlRMTZNV21nQ0tZWVBDc05UbExWZG9nNThNdWRRcmxpSkh6NA?oc=5</link><guid isPermaLink="false">CBMiUkFVX3lxTFBaNUxvN0U2ckZob0tjc3Y2dWYxUGExUHNiWW1yaU93N1BNUHlTUll0SFNJMVBKemkwYndWcjBSWVNtQ1ZROXI0YTBNYUJWTlgza1HSAVNBVV95cUxNMWgwMm5pUlVKbHIxZVFmcExOQUkwSkI0UFBrSFU3XzZDMnNhT3ZIbWlRMTZNV21nQ0tZWVBDc05UbExWZG9nNThNdWRRcmxpSkh6NA</guid><pubDate>Wed, 10 Jun 2026 06:49:44 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTFBaNUxvN0U2ckZob0tjc3Y2dWYxUGExUHNiWW1yaU93N1BNUHlTUll0SFNJMVBKemkwYndWcjBSWVNtQ1ZROXI0YTBNYUJWTlgza1HSAVNBVV95cUxNMWgwMm5pUlVKbHIxZVFmcExOQUkwSkI0UFBrSFU3XzZDMnNhT3ZIbWlRMTZNV21nQ0tZWVBDc05UbExWZG9nNThNdWRRcmxpSkh6NA?oc=5" target="_blank"&gt;알테오젠, ADC 적용 피하주사 제형화 전임상 결과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제&lt;/font&gt;</description><source url="https://www.sedaily.com">서울경제</source></item><item><title>셀트리온, HER2 타깃 CT-P72 전임상서 고발현 선택성·내약성 확인 - PRESS9</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE5jUWZHeG1NaTFOM1Q3OVhrczFWTGxES2VkdXFKOThvM1Bpa1R6UHljYmVieG1YS2tSdmFYX1JFQkFZc2ZzMDFZeVNsMlBwT2oxcGVUR1FDYU10LW56ZTVvQS1RcDV4UQ?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE5jUWZHeG1NaTFOM1Q3OVhrczFWTGxES2VkdXFKOThvM1Bpa1R6UHljYmVieG1YS2tSdmFYX1JFQkFZc2ZzMDFZeVNsMlBwT2oxcGVUR1FDYU10LW56ZTVvQS1RcDV4UQ</guid><pubDate>Thu, 11 Jun 2026 23:34:16 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE5jUWZHeG1NaTFOM1Q3OVhrczFWTGxES2VkdXFKOThvM1Bpa1R6UHljYmVieG1YS2tSdmFYX1JFQkFZc2ZzMDFZeVNsMlBwT2oxcGVUR1FDYU10LW56ZTVvQS1RcDV4UQ?oc=5" target="_blank"&gt;셀트리온, HER2 타깃 CT-P72 전임상서 고발현 선택성·내약성 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PRESS9&lt;/font&gt;</description><source url="https://www.press9.kr">PRESS9</source></item><item><title>프로티나, 美 ADA 2026서 비만 치료제 후보물질 ‘PRT-1309’ 전임상 연구결과 발표 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5pWjFPcFAwR1RhVTBuU0FVNmNEay0zWnFNWGxYSWRHVDhmVlFtcm5pQ0lYT3pHaUstOUdRbENOMW1ubWxIeUxQcXFxdDNMaWZhdEFGRjBhd0ZCbWdFOFVsM1BqRjI2dXI3TGV3eQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5pWjFPcFAwR1RhVTBuU0FVNmNEay0zWnFNWGxYSWRHVDhmVlFtcm5pQ0lYT3pHaUstOUdRbENOMW1ubWxIeUxQcXFxdDNMaWZhdEFGRjBhd0ZCbWdFOFVsM1BqRjI2dXI3TGV3eQ</guid><pubDate>Tue, 09 Jun 2026 06:52:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5pWjFPcFAwR1RhVTBuU0FVNmNEay0zWnFNWGxYSWRHVDhmVlFtcm5pQ0lYT3pHaUstOUdRbENOMW1ubWxIeUxQcXFxdDNMaWZhdEFGRjBhd0ZCbWdFOFVsM1BqRjI2dXI3TGV3eQ?oc=5" target="_blank"&gt;프로티나, 美 ADA 2026서 비만 치료제 후보물질 ‘PRT-1309’ 전임상 연구결과 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>지투지바이오, 비만 '이중·삼중작용제' 전임상 "ADA 발표" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFBYQXhpaFdja3lIekpoUmFVdDQ4QkJQdXJTa2twaElEbnBPdDhEbGNacXhST0l0ZGhvSlFGdV9KZDhuWVg5RFFOSU5hRVhCWnlmLTFHNGdOYw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFBYQXhpaFdja3lIekpoUmFVdDQ4QkJQdXJTa2twaElEbnBPdDhEbGNacXhST0l0ZGhvSlFGdV9KZDhuWVg5RFFOSU5hRVhCWnlmLTFHNGdOYw</guid><pubDate>Mon, 08 Jun 2026 02:58:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFBYQXhpaFdja3lIekpoUmFVdDQ4QkJQdXJTa2twaElEbnBPdDhEbGNacXhST0l0ZGhvSlFGdV9KZDhuWVg5RFFOSU5hRVhCWnlmLTFHNGdOYw?oc=5" target="_blank"&gt;지투지바이오, 비만 '이중·삼중작용제' 전임상 "ADA 발표"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>[ADA] 프로티나, GIPR 길항 항체 전임상서 위고비 병용시 최대 26.8% 체중↓ - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5ROEliOS1KMHZPaGxzTERibEYya2dxZXRJS1JVd1ZEUERMTmJfaEJzN29zSHBuTU51b0pTUEhKWWl4cnVvckJhU3ZNclRsS0JKT1lCQlJ6M1Q2OTJWaU5ndXZ4TUFJem5EaWNRUNIBcEFVX3lxTE94STBvN0d0MDVOV0lLS2xkSTlZckMxRFhwM2hMbDB2NjBHS2M5N0dZYlAwUWRqTmFCbDBpSUY5ZFBwMmpjRFoxX1plNzdkOVpoYjBFZ0Zpd25fUVF6T2RXRlhxVFJqMElfbmNzRGMwdEM?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5ROEliOS1KMHZPaGxzTERibEYya2dxZXRJS1JVd1ZEUERMTmJfaEJzN29zSHBuTU51b0pTUEhKWWl4cnVvckJhU3ZNclRsS0JKT1lCQlJ6M1Q2OTJWaU5ndXZ4TUFJem5EaWNRUNIBcEFVX3lxTE94STBvN0d0MDVOV0lLS2xkSTlZckMxRFhwM2hMbDB2NjBHS2M5N0dZYlAwUWRqTmFCbDBpSUY5ZFBwMmpjRFoxX1plNzdkOVpoYjBFZ0Zpd25fUVF6T2RXRlhxVFJqMElfbmNzRGMwdEM</guid><pubDate>Tue, 09 Jun 2026 01:32:44 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5ROEliOS1KMHZPaGxzTERibEYya2dxZXRJS1JVd1ZEUERMTmJfaEJzN29zSHBuTU51b0pTUEhKWWl4cnVvckJhU3ZNclRsS0JKT1lCQlJ6M1Q2OTJWaU5ndXZ4TUFJem5EaWNRUNIBcEFVX3lxTE94STBvN0d0MDVOV0lLS2xkSTlZckMxRFhwM2hMbDB2NjBHS2M5N0dZYlAwUWRqTmFCbDBpSUY5ZFBwMmpjRFoxX1plNzdkOVpoYjBFZ0Zpd25fUVF6T2RXRlhxVFJqMElfbmNzRGMwdEM?oc=5" target="_blank"&gt;[ADA] 프로티나, GIPR 길항 항체 전임상서 위고비 병용시 최대 26.8% 체중↓&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>알테오젠, World ADC서 ALT-B4 전임상 결과 공개 - fetv.co.kr</title><link>https://news.google.com/rss/articles/CBMiaEFVX3lxTE5samRkMktfRFpINUREdzNkUUFwandTM2JsaF9KajNHbTlxM1ctQU1PUDI3cS1jTFNOLUE0UDRmYTI5YjVHWXEyZTBCeVVlZnYwNERON1FhaFRuMkR5el9yYS1MOVNXTkhG?oc=5</link><guid isPermaLink="false">CBMiaEFVX3lxTE5samRkMktfRFpINUREdzNkUUFwandTM2JsaF9KajNHbTlxM1ctQU1PUDI3cS1jTFNOLUE0UDRmYTI5YjVHWXEyZTBCeVVlZnYwNERON1FhaFRuMkR5el9yYS1MOVNXTkhG</guid><pubDate>Wed, 10 Jun 2026 06:50:57 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE5samRkMktfRFpINUREdzNkUUFwandTM2JsaF9KajNHbTlxM1ctQU1PUDI3cS1jTFNOLUE0UDRmYTI5YjVHWXEyZTBCeVVlZnYwNERON1FhaFRuMkR5el9yYS1MOVNXTkhG?oc=5" target="_blank"&gt;알테오젠, World ADC서 ALT-B4 전임상 결과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;fetv.co.kr&lt;/font&gt;</description><source url="https://www.fetv.co.kr">fetv.co.kr</source></item><item><title>영업익 '반토막' 대원제약...비만약 훈풍에 가려진 실적 그늘 - 팜뉴스</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1MdHpzRHRJbl90VWhQM1JEYlY0dDVZd2NWbngydUhIZHU1akdOZFRjU0RtQTlrVXp1Wkw2bFlOZi16Rk85SDFVUmNMQzBITFlVM3FoWWdzR1ROZ2RWQUdabTNvLXZzajFxYzRGYg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1MdHpzRHRJbl90VWhQM1JEYlY0dDVZd2NWbngydUhIZHU1akdOZFRjU0RtQTlrVXp1Wkw2bFlOZi16Rk85SDFVUmNMQzBITFlVM3FoWWdzR1ROZ2RWQUdabTNvLXZzajFxYzRGYg</guid><pubDate>Tue, 09 Jun 2026 20:59:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1MdHpzRHRJbl90VWhQM1JEYlY0dDVZd2NWbngydUhIZHU1akdOZFRjU0RtQTlrVXp1Wkw2bFlOZi16Rk85SDFVUmNMQzBITFlVM3FoWWdzR1ROZ2RWQUdabTNvLXZzajFxYzRGYg?oc=5" target="_blank"&gt;영업익 '반토막' 대원제약...비만약 훈풍에 가려진 실적 그늘&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜뉴스&lt;/font&gt;</description><source url="https://www.pharmnews.com">팜뉴스</source></item><item><title>프로티나 PRT-1309 전임상 업데이트: 일라이 릴리 &amp; 노보 노디스크 비만약과의 병용 가능성 - 네이버 프리미엄콘텐츠</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxOMUFZT2J0OGNnYU5DeVhNdkhteldOOS1lckxrZUc3WVRLQm5oYTJ1MTgxRncxWXJGZGRJcnhBOFFYcVlWTWw5aWdENXhIYVotSVdPVlkwcE9UZFpjTlNSbGxGdFhoZExaT2p6bzFZYkVzclphVmFSNnNaUWpGcTR6VEE4Tmg0ek0?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxOMUFZT2J0OGNnYU5DeVhNdkhteldOOS1lckxrZUc3WVRLQm5oYTJ1MTgxRncxWXJGZGRJcnhBOFFYcVlWTWw5aWdENXhIYVotSVdPVlkwcE9UZFpjTlNSbGxGdFhoZExaT2p6bzFZYkVzclphVmFSNnNaUWpGcTR6VEE4Tmg0ek0</guid><pubDate>Thu, 11 Jun 2026 01:27:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxOMUFZT2J0OGNnYU5DeVhNdkhteldOOS1lckxrZUc3WVRLQm5oYTJ1MTgxRncxWXJGZGRJcnhBOFFYcVlWTWw5aWdENXhIYVotSVdPVlkwcE9UZFpjTlNSbGxGdFhoZExaT2p6bzFZYkVzclphVmFSNnNaUWpGcTR6VEE4Tmg0ek0?oc=5" target="_blank"&gt;프로티나 PRT-1309 전임상 업데이트: 일라이 릴리 &amp; 노보 노디스크 비만약과의 병용 가능성&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이버 프리미엄콘텐츠&lt;/font&gt;</description><source url="https://contents.premium.naver.com">네이버 프리미엄콘텐츠</source></item><item><title>셀트리온, 항암 신약 'CT-P72' 전임상서 효능 입증 - 메디컬투데이</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1nUUdfYnZrQ0o1ZURtemVCWks4M1U2bDk1Y3kycEFuR0hFcDJGTUJ6OUNvam0tOFQzX2w5bGJ3MlZNT2I3RmtEZ1JtOGNhZDJ6a1A2VVQ4bHdyTTRhblEycTh6UGU3UHZZOGdNWg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1nUUdfYnZrQ0o1ZURtemVCWks4M1U2bDk1Y3kycEFuR0hFcDJGTUJ6OUNvam0tOFQzX2w5bGJ3MlZNT2I3RmtEZ1JtOGNhZDJ6a1A2VVQ4bHdyTTRhblEycTh6UGU3UHZZOGdNWg</guid><pubDate>Fri, 12 Jun 2026 09:22:28 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1nUUdfYnZrQ0o1ZURtemVCWks4M1U2bDk1Y3kycEFuR0hFcDJGTUJ6OUNvam0tOFQzX2w5bGJ3MlZNT2I3RmtEZ1JtOGNhZDJ6a1A2VVQ4bHdyTTRhblEycTh6UGU3UHZZOGdNWg?oc=5" target="_blank"&gt;셀트리온, 항암 신약 'CT-P72' 전임상서 효능 입증&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디컬투데이&lt;/font&gt;</description><source url="https://www.mdtoday.co.kr">메디컬투데이</source></item><item><title>셀트리온, 차세대 다중항체 신약 'CT-P72' 전임상 순항 - 폴리뉴스 Polinews</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTE5YRVhjSU56enByOTdOVW9ibVl6dUk4Y1V6VFNkaDdGOHlKNnhEVUszX1JYek5jbm82VWQ2cVUzSzFtZ1VLYWZYTEF3dlFtbWtSWWYyMDVrX1k0ZnBKellxU0k3SERWb09Da3VQR2dR0gFyQVVfeXFMTWpTbFBRR1E2MlE0T0wzZWhCNHdwelhkMU9hb0J3TUlMbm9PcjNYMVlUWENveGZXMVpnXzFlUXVkVGZEYmZxTHhISlFJT2FlaThMYnRFQ3p4Slkzd2YtSk1tbVRCOVhtOFhOaWhQTms5elRB?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTE5YRVhjSU56enByOTdOVW9ibVl6dUk4Y1V6VFNkaDdGOHlKNnhEVUszX1JYek5jbm82VWQ2cVUzSzFtZ1VLYWZYTEF3dlFtbWtSWWYyMDVrX1k0ZnBKellxU0k3SERWb09Da3VQR2dR0gFyQVVfeXFMTWpTbFBRR1E2MlE0T0wzZWhCNHdwelhkMU9hb0J3TUlMbm9PcjNYMVlUWENveGZXMVpnXzFlUXVkVGZEYmZxTHhISlFJT2FlaThMYnRFQ3p4Slkzd2YtSk1tbVRCOVhtOFhOaWhQTms5elRB</guid><pubDate>Fri, 12 Jun 2026 06:50:48 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTE5YRVhjSU56enByOTdOVW9ibVl6dUk4Y1V6VFNkaDdGOHlKNnhEVUszX1JYek5jbm82VWQ2cVUzSzFtZ1VLYWZYTEF3dlFtbWtSWWYyMDVrX1k0ZnBKellxU0k3SERWb09Da3VQR2dR0gFyQVVfeXFMTWpTbFBRR1E2MlE0T0wzZWhCNHdwelhkMU9hb0J3TUlMbm9PcjNYMVlUWENveGZXMVpnXzFlUXVkVGZEYmZxTHhISlFJT2FlaThMYnRFQ3p4Slkzd2YtSk1tbVRCOVhtOFhOaWhQTms5elRB?oc=5" target="_blank"&gt;셀트리온, 차세대 다중항체 신약 'CT-P72' 전임상 순항&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;폴리뉴스 Polinews&lt;/font&gt;</description><source url="https://www.polinews.co.kr">폴리뉴스 Polinews</source></item><item><title>풀백, EHA 학회서 POLB 001 전임상 데이터 발표 - Investing.com 한국어</title><link>https://news.google.com/rss/articles/CBMicEFVX3lxTE04dW92eE4zcEFJaHVfbmYtQUR5WDJQTzZmVWVLTS1lZW1uNlBJZmxzZHlRRDVaUXRscF9peTk2Z2ZLaGpxQlA5UjV6ajBVcTJVSm10MWdCV2xZc1F0eGlDY0dva0dmdml1UTFEczFjV1M?oc=5</link><guid isPermaLink="false">CBMicEFVX3lxTE04dW92eE4zcEFJaHVfbmYtQUR5WDJQTzZmVWVLTS1lZW1uNlBJZmxzZHlRRDVaUXRscF9peTk2Z2ZLaGpxQlA5UjV6ajBVcTJVSm10MWdCV2xZc1F0eGlDY0dva0dmdml1UTFEczFjV1M</guid><pubDate>Thu, 11 Jun 2026 07:01:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE04dW92eE4zcEFJaHVfbmYtQUR5WDJQTzZmVWVLTS1lZW1uNlBJZmxzZHlRRDVaUXRscF9peTk2Z2ZLaGpxQlA5UjV6ajBVcTJVSm10MWdCV2xZc1F0eGlDY0dva0dmdml1UTFEczFjV1M?oc=5" target="_blank"&gt;풀백, EHA 학회서 POLB 001 전임상 데이터 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Investing.com 한국어&lt;/font&gt;</description><source url="https://kr.investing.com">Investing.com 한국어</source></item><item><title>프로티나, ADA서 비만 치료제 전임상 데이터 공개 - 뉴스핌</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTFBUMnQyR1plTlF4b25pUGdad0ZtM2w2TDVRYWxnbktIOFNUYUlGYUgyWXhSMEg5elN2NVdDNE05eHdrUVk5MTNwaFpfOGd0TDAtbnIxbG5KN3JJdXMz?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTFBUMnQyR1plTlF4b25pUGdad0ZtM2w2TDVRYWxnbktIOFNUYUlGYUgyWXhSMEg5elN2NVdDNE05eHdrUVk5MTNwaFpfOGd0TDAtbnIxbG5KN3JJdXMz</guid><pubDate>Tue, 09 Jun 2026 01:16:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTFBUMnQyR1plTlF4b25pUGdad0ZtM2w2TDVRYWxnbktIOFNUYUlGYUgyWXhSMEg5elN2NVdDNE05eHdrUVk5MTNwaFpfOGd0TDAtbnIxbG5KN3JJdXMz?oc=5" target="_blank"&gt;프로티나, ADA서 비만 치료제 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스핌&lt;/font&gt;</description><source url="https://www.newspim.com">뉴스핌</source></item><item><title>대원제약, ADA서 4중 비만치료제 전임상 데이터 발표 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5oMjRoRGl2clhGcEFsLXQwWVFYRDhabnFETEhSR2FPZ3N4bDhDaFRKRXphaUtpMWtKX0YtS3JuR1NxWVJNVmRFSWJVUHpmdTQtZ3BtcFhGTFJLUTBkUjJKWHlWbjRDb0lrejIzeg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5oMjRoRGl2clhGcEFsLXQwWVFYRDhabnFETEhSR2FPZ3N4bDhDaFRKRXphaUtpMWtKX0YtS3JuR1NxWVJNVmRFSWJVUHpmdTQtZ3BtcFhGTFJLUTBkUjJKWHlWbjRDb0lrejIzeg</guid><pubDate>Thu, 04 Jun 2026 02:48:30 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5oMjRoRGl2clhGcEFsLXQwWVFYRDhabnFETEhSR2FPZ3N4bDhDaFRKRXphaUtpMWtKX0YtS3JuR1NxWVJNVmRFSWJVUHpmdTQtZ3BtcFhGTFJLUTBkUjJKWHlWbjRDb0lrejIzeg?oc=5" target="_blank"&gt;대원제약, ADA서 4중 비만치료제 전임상 데이터 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>바이젠셀, EACR서 교모세포종 'VC302' 전임상 결과 발표 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBPZ0xUb2ZUNVkzUE1tdHhEV3YyRzU4azE0Z2IycWs3Mmo0bEFySTZXdTBRUG9ublZoQnVWVzhXU2tDdjZyTTBsYkpYazNzUFVoWWZPamxITVZEUms2ZHo5RWhuRjAtZ0VGT3pv?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBPZ0xUb2ZUNVkzUE1tdHhEV3YyRzU4azE0Z2IycWs3Mmo0bEFySTZXdTBRUG9ublZoQnVWVzhXU2tDdjZyTTBsYkpYazNzUFVoWWZPamxITVZEUms2ZHo5RWhuRjAtZ0VGT3pv</guid><pubDate>Mon, 08 Jun 2026 01:27:20 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBPZ0xUb2ZUNVkzUE1tdHhEV3YyRzU4azE0Z2IycWs3Mmo0bEFySTZXdTBRUG9ublZoQnVWVzhXU2tDdjZyTTBsYkpYazNzUFVoWWZPamxITVZEUms2ZHo5RWhuRjAtZ0VGT3pv?oc=5" target="_blank"&gt;바이젠셀, EACR서 교모세포종 'VC302' 전임상 결과 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>지투지바이오, ADA서 이중·삼중 작용제 전임상 데이터 공개 - 메디파나뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE92dmc5R29JVVg1YTYtSHFmU0ZCYUJLdXFOV0dQdkgyd2Z6MXByWk1jTWtQLTJiNHB5ZF9TRzRGQmZZYzVxTktHS1RyLTJsRUxCQ1BLZ2FVUWZ0aC1BX29CZUpSRjVhS3JLb2NN?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE92dmc5R29JVVg1YTYtSHFmU0ZCYUJLdXFOV0dQdkgyd2Z6MXByWk1jTWtQLTJiNHB5ZF9TRzRGQmZZYzVxTktHS1RyLTJsRUxCQ1BLZ2FVUWZ0aC1BX29CZUpSRjVhS3JLb2NN</guid><pubDate>Mon, 08 Jun 2026 02:30:07 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE92dmc5R29JVVg1YTYtSHFmU0ZCYUJLdXFOV0dQdkgyd2Z6MXByWk1jTWtQLTJiNHB5ZF9TRzRGQmZZYzVxTktHS1RyLTJsRUxCQ1BLZ2FVUWZ0aC1BX29CZUpSRjVhS3JLb2NN?oc=5" target="_blank"&gt;지투지바이오, ADA서 이중·삼중 작용제 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디파나뉴스&lt;/font&gt;</description><source url="https://www.medipana.com">메디파나뉴스</source></item><item><title>셀트리온, HER2 다중항체 신약 전임상서 항암 효능 확인 - 이뉴스투데이</title><link>https://news.google.com/rss/articles/CBMicEFVX3lxTE1NN05ucnlIVmE2TVR4SzJ2VzQ0TFhhem9JUnItbG5LakJTOW5xTVVjNlltOHV6ZWlGR0lpSHJKcjYtM3A3cDJ5bm12Mm5LeXQ4aVp1dU1QbVpzSVBtUDZQWm9FUkdhdnR2OC1DSWNWdVnSAXRBVV95cUxQRkNIU2VDYXJZanBWZ3ZLSzJuTWhUc2FZNTR1NUY2MHJsZXZCQlUyOFVhVmFxUUhub1R4SGtVeTYyUG1rczJROFVzZ0pvSzhxOFJZZGhtT21Rem9ES2oxTkZpblhSSEFJaTVWVmN4ZlhIVVlQTA?oc=5</link><guid isPermaLink="false">CBMicEFVX3lxTE1NN05ucnlIVmE2TVR4SzJ2VzQ0TFhhem9JUnItbG5LakJTOW5xTVVjNlltOHV6ZWlGR0lpSHJKcjYtM3A3cDJ5bm12Mm5LeXQ4aVp1dU1QbVpzSVBtUDZQWm9FUkdhdnR2OC1DSWNWdVnSAXRBVV95cUxQRkNIU2VDYXJZanBWZ3ZLSzJuTWhUc2FZNTR1NUY2MHJsZXZCQlUyOFVhVmFxUUhub1R4SGtVeTYyUG1rczJROFVzZ0pvSzhxOFJZZGhtT21Rem9ES2oxTkZpblhSSEFJaTVWVmN4ZlhIVVlQTA</guid><pubDate>Fri, 12 Jun 2026 00:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE1NN05ucnlIVmE2TVR4SzJ2VzQ0TFhhem9JUnItbG5LakJTOW5xTVVjNlltOHV6ZWlGR0lpSHJKcjYtM3A3cDJ5bm12Mm5LeXQ4aVp1dU1QbVpzSVBtUDZQWm9FUkdhdnR2OC1DSWNWdVnSAXRBVV95cUxQRkNIU2VDYXJZanBWZ3ZLSzJuTWhUc2FZNTR1NUY2MHJsZXZCQlUyOFVhVmFxUUhub1R4SGtVeTYyUG1rczJROFVzZ0pvSzhxOFJZZGhtT21Rem9ES2oxTkZpblhSSEFJaTVWVmN4ZlhIVVlQTA?oc=5" target="_blank"&gt;셀트리온, HER2 다중항체 신약 전임상서 항암 효능 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;이뉴스투데이&lt;/font&gt;</description><source url="http://www.enewstoday.co.kr">이뉴스투데이</source></item><item><title>프로티나, ADA 2026서 차세대 비만 치료제 전임상 데이터 공개 - 이데일리</title><link>https://news.google.com/rss/articles/CBMigAFBVV95cUxNMld6MWtJUlFmRF84Ml9OakZISFhqbHRhMjBWSHRuWGtJT2JiX09TTnJ2eHhGNk5DcU9XRm1VWnQ3ZUVZNlotR3B2cnRSQ1l1WjBzRVVEcTlkWDl1bExvdlphMUc5OGVoQWl2SjdQdGVEOGlrZlZhd1F2dW1fQ1hJcQ?oc=5</link><guid isPermaLink="false">CBMigAFBVV95cUxNMld6MWtJUlFmRF84Ml9OakZISFhqbHRhMjBWSHRuWGtJT2JiX09TTnJ2eHhGNk5DcU9XRm1VWnQ3ZUVZNlotR3B2cnRSQ1l1WjBzRVVEcTlkWDl1bExvdlphMUc5OGVoQWl2SjdQdGVEOGlrZlZhd1F2dW1fQ1hJcQ</guid><pubDate>Tue, 09 Jun 2026 01:19:56 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxNMld6MWtJUlFmRF84Ml9OakZISFhqbHRhMjBWSHRuWGtJT2JiX09TTnJ2eHhGNk5DcU9XRm1VWnQ3ZUVZNlotR3B2cnRSQ1l1WjBzRVVEcTlkWDl1bExvdlphMUc5OGVoQWl2SjdQdGVEOGlrZlZhd1F2dW1fQ1hJcQ?oc=5" target="_blank"&gt;프로티나, ADA 2026서 차세대 비만 치료제 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;이데일리&lt;/font&gt;</description><source url="https://www.edaily.co.kr">이데일리</source></item><item><title>셀트리온, 차세대 다중항체 신약 전임상 성과 공개 - 핀포인트뉴스</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE0ydzNpT2xvRC04UmxyWU50bjlDMURJVVB6MHBDaTczbXNjRFJpbnY2NmFJQUVGaGV2NGdIRXFxOUVkWjZUQnFvaURobEJ0UHZxZlpnQlNlQU5JRDRnMTlDc3huaGYyRk9OOUY4QkVWQnUwSDjSAXdBVV95cUxPMGpkaVpuQnFjN2F4aGxzX1lKYzE3dG5QcW1pVmxWcGFlVnRsd0k0U0VaNkhHWkRHUXpieDFKSWp2WHJQd3MzYmk5UnRiU09hVG1ncXBrZmRyUmZLeHRQenIyUTRwcDJhcktSb1FTcjRVeGRTWWd4cw?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE0ydzNpT2xvRC04UmxyWU50bjlDMURJVVB6MHBDaTczbXNjRFJpbnY2NmFJQUVGaGV2NGdIRXFxOUVkWjZUQnFvaURobEJ0UHZxZlpnQlNlQU5JRDRnMTlDc3huaGYyRk9OOUY4QkVWQnUwSDjSAXdBVV95cUxPMGpkaVpuQnFjN2F4aGxzX1lKYzE3dG5QcW1pVmxWcGFlVnRsd0k0U0VaNkhHWkRHUXpieDFKSWp2WHJQd3MzYmk5UnRiU09hVG1ncXBrZmRyUmZLeHRQenIyUTRwcDJhcktSb1FTcjRVeGRTWWd4cw</guid><pubDate>Thu, 11 Jun 2026 23:17:56 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE0ydzNpT2xvRC04UmxyWU50bjlDMURJVVB6MHBDaTczbXNjRFJpbnY2NmFJQUVGaGV2NGdIRXFxOUVkWjZUQnFvaURobEJ0UHZxZlpnQlNlQU5JRDRnMTlDc3huaGYyRk9OOUY4QkVWQnUwSDjSAXdBVV95cUxPMGpkaVpuQnFjN2F4aGxzX1lKYzE3dG5QcW1pVmxWcGFlVnRsd0k0U0VaNkhHWkRHUXpieDFKSWp2WHJQd3MzYmk5UnRiU09hVG1ncXBrZmRyUmZLeHRQenIyUTRwcDJhcktSb1FTcjRVeGRTWWd4cw?oc=5" target="_blank"&gt;셀트리온, 차세대 다중항체 신약 전임상 성과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;핀포인트뉴스&lt;/font&gt;</description><source url="https://www.pinpointnews.co.kr">핀포인트뉴스</source></item><item><title>바이젠셀, EACR서 교모세포종 치료제 후보물질 ‘VC302’ 전임상 결과 발표 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE1zaEZtTlQ1dlpUTjZpcGhha3BFNXNtVy1SREJBUmU5VV9zeXMzXzdIb1R3eVFSQTJGSFYtcXE2TUVJUkFiVXdnTWdoRThWY2NOUmJPb2ZJS19rUXIzdEh0aXc5NzdMNnJxWjM3adIBcEFVX3lxTFB5ZzN4ajZvVGpOTDRPMlA4cmhrYnB2cWJVYjgxX2VrVXp4Wnk1UnEwU1BPQ3VsZUw1Z0lOSHJiclpyQ0RIaGJXcXlmRVBVOVA0SFNjWHpRaS1nRUt5UHlMMThhUExUNWNYckpweWhFeDI?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE1zaEZtTlQ1dlpUTjZpcGhha3BFNXNtVy1SREJBUmU5VV9zeXMzXzdIb1R3eVFSQTJGSFYtcXE2TUVJUkFiVXdnTWdoRThWY2NOUmJPb2ZJS19rUXIzdEh0aXc5NzdMNnJxWjM3adIBcEFVX3lxTFB5ZzN4ajZvVGpOTDRPMlA4cmhrYnB2cWJVYjgxX2VrVXp4Wnk1UnEwU1BPQ3VsZUw1Z0lOSHJiclpyQ0RIaGJXcXlmRVBVOVA0SFNjWHpRaS1nRUt5UHlMMThhUExUNWNYckpweWhFeDI</guid><pubDate>Mon, 08 Jun 2026 01:07:11 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE1zaEZtTlQ1dlpUTjZpcGhha3BFNXNtVy1SREJBUmU5VV9zeXMzXzdIb1R3eVFSQTJGSFYtcXE2TUVJUkFiVXdnTWdoRThWY2NOUmJPb2ZJS19rUXIzdEh0aXc5NzdMNnJxWjM3adIBcEFVX3lxTFB5ZzN4ajZvVGpOTDRPMlA4cmhrYnB2cWJVYjgxX2VrVXp4Wnk1UnEwU1BPQ3VsZUw1Z0lOSHJiclpyQ0RIaGJXcXlmRVBVOVA0SFNjWHpRaS1nRUt5UHlMMThhUExUNWNYckpweWhFeDI?oc=5" target="_blank"&gt;바이젠셀, EACR서 교모세포종 치료제 후보물질 ‘VC302’ 전임상 결과 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>셀트리온, 차세대 항암 신약 ‘CT-P72/ABP-102’ 전임상서 독보적 효능 및 안전성 확인 - 인사이트코리아</title><link>https://news.google.com/rss/articles/CBMic0FVX3lxTE1Ha2pibWg1cnM3eExGcm5WX01HOC1wR2FTck04Tm5IOTRVMElteG92UHhuUHJoc09MUUJsWVY5b3ctS1FIYkVWUGhtQnctQmN4QzRpak9rQ2duenYxbHlSaFRIb0hHQkJlRjZIeWJ1S3EzQ1XSAXdBVV95cUxQYmJLZllxYUlub1VYM3hpRWVudGlJV0NmTGJOUXY3MHQ4SlI3dlhjVmtJLWlRazZjNEFLeGhsR2tBTzBGTFdUeGxDanQ5OFdCZU1NeE1MdkQ3T0M3cDBJQzZ1M0RxMElZT1UzdUZUWkh6clZ2el9POA?oc=5</link><guid isPermaLink="false">CBMic0FVX3lxTE1Ha2pibWg1cnM3eExGcm5WX01HOC1wR2FTck04Tm5IOTRVMElteG92UHhuUHJoc09MUUJsWVY5b3ctS1FIYkVWUGhtQnctQmN4QzRpak9rQ2duenYxbHlSaFRIb0hHQkJlRjZIeWJ1S3EzQ1XSAXdBVV95cUxQYmJLZllxYUlub1VYM3hpRWVudGlJV0NmTGJOUXY3MHQ4SlI3dlhjVmtJLWlRazZjNEFLeGhsR2tBTzBGTFdUeGxDanQ5OFdCZU1NeE1MdkQ3T0M3cDBJQzZ1M0RxMElZT1UzdUZUWkh6clZ2el9POA</guid><pubDate>Fri, 12 Jun 2026 01:33:03 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMic0FVX3lxTE1Ha2pibWg1cnM3eExGcm5WX01HOC1wR2FTck04Tm5IOTRVMElteG92UHhuUHJoc09MUUJsWVY5b3ctS1FIYkVWUGhtQnctQmN4QzRpak9rQ2duenYxbHlSaFRIb0hHQkJlRjZIeWJ1S3EzQ1XSAXdBVV95cUxQYmJLZllxYUlub1VYM3hpRWVudGlJV0NmTGJOUXY3MHQ4SlI3dlhjVmtJLWlRazZjNEFLeGhsR2tBTzBGTFdUeGxDanQ5OFdCZU1NeE1MdkQ3T0M3cDBJQzZ1M0RxMElZT1UzdUZUWkh6clZ2el9POA?oc=5" target="_blank"&gt;셀트리온, 차세대 항암 신약 ‘CT-P72/ABP-102’ 전임상서 독보적 효능 및 안전성 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;인사이트코리아&lt;/font&gt;</description><source url="https://www.insightkorea.co.kr">인사이트코리아</source></item><item><title>인벤티지랩, 월 1회 비만약 전임상 결과 미국당뇨병학회서 발표 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE5HMnlwVmNtNWdSdEl1MVlISkFGR2NyeE1vdUthOEJHY2hzTWt1b0g1N2RvNm1HUnN4RDU4T0dxYmJRUUxtQ2dpZm9CdnpwX3ZYWTNqNmRfRnFwd9IBVEFVX3lxTE5GaEN5SHRjYUZXYmY4OENaMVdpM2UzU0c4OVJsa0w0SUJqQjgzSzVRQzJoSjZ4NlpqQ3ZkU3V0THBPbXRoWWlyVzRPS0RlWS1aZ2ZFYQ?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE5HMnlwVmNtNWdSdEl1MVlISkFGR2NyeE1vdUthOEJHY2hzTWt1b0g1N2RvNm1HUnN4RDU4T0dxYmJRUUxtQ2dpZm9CdnpwX3ZYWTNqNmRfRnFwd9IBVEFVX3lxTE5GaEN5SHRjYUZXYmY4OENaMVdpM2UzU0c4OVJsa0w0SUJqQjgzSzVRQzJoSjZ4NlpqQ3ZkU3V0THBPbXRoWWlyVzRPS0RlWS1aZ2ZFYQ</guid><pubDate>Mon, 08 Jun 2026 01:12:32 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE5HMnlwVmNtNWdSdEl1MVlISkFGR2NyeE1vdUthOEJHY2hzTWt1b0g1N2RvNm1HUnN4RDU4T0dxYmJRUUxtQ2dpZm9CdnpwX3ZYWTNqNmRfRnFwd9IBVEFVX3lxTE5GaEN5SHRjYUZXYmY4OENaMVdpM2UzU0c4OVJsa0w0SUJqQjgzSzVRQzJoSjZ4NlpqQ3ZkU3V0THBPbXRoWWlyVzRPS0RlWS1aZ2ZFYQ?oc=5" target="_blank"&gt;인벤티지랩, 월 1회 비만약 전임상 결과 미국당뇨병학회서 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>지투지바이오, 당뇨병학회서 '이중·삼중 작용제' 전임상 데이터 공개 - 뉴스1</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTFA5Q2FXMnlEWWhJTmlreVlaWW1Tb3lWSkl1Rjk1ZTE4OEw0eTl2Q2Yxd1NreDNrcEZlTG93VXgtMGxEeUJqRFktNXBUMGtPeDI4WGFKajZLYWFqZ1Z3Wk1YQw?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTFA5Q2FXMnlEWWhJTmlreVlaWW1Tb3lWSkl1Rjk1ZTE4OEw0eTl2Q2Yxd1NreDNrcEZlTG93VXgtMGxEeUJqRFktNXBUMGtPeDI4WGFKajZLYWFqZ1Z3Wk1YQw</guid><pubDate>Mon, 08 Jun 2026 06:28:29 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFA5Q2FXMnlEWWhJTmlreVlaWW1Tb3lWSkl1Rjk1ZTE4OEw0eTl2Q2Yxd1NreDNrcEZlTG93VXgtMGxEeUJqRFktNXBUMGtPeDI4WGFKajZLYWFqZ1Z3Wk1YQw?oc=5" target="_blank"&gt;지투지바이오, 당뇨병학회서 '이중·삼중 작용제' 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스1&lt;/font&gt;</description><source url="https://www.news1.kr">뉴스1</source></item><item><title>셀트리온 'HER2 다중항체 신약 전임상서 항암 효과 확인' - 데일리한국</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE81RjFMNTdfQVhlYTJ6OEVsS1RzTEtSbHdSbHlrV21jRG1uNmNZaTMxT0cwYWFMdG1GZ1pqbTNENHdZb20wbV9TYXNjNXFUMVB4QXJNeldhVFhiQzRzVDlUb184V0diblZvT2U3VFNwMNIBc0FVX3lxTE1zaFEzbzVPSndFMndPSXlUN3lpZXptU2hkTFFveGhEeU1NemFrSEs2bjFrYUU3UEN1VnlmQm5tMjhERkRRaHd5VTRZR2pWd2VGWFhkRHFiclplVDRYaUtiUkZ4ekZ2ZFhETy0yT1dVam5PSTg?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE81RjFMNTdfQVhlYTJ6OEVsS1RzTEtSbHdSbHlrV21jRG1uNmNZaTMxT0cwYWFMdG1GZ1pqbTNENHdZb20wbV9TYXNjNXFUMVB4QXJNeldhVFhiQzRzVDlUb184V0diblZvT2U3VFNwMNIBc0FVX3lxTE1zaFEzbzVPSndFMndPSXlUN3lpZXptU2hkTFFveGhEeU1NemFrSEs2bjFrYUU3UEN1VnlmQm5tMjhERkRRaHd5VTRZR2pWd2VGWFhkRHFiclplVDRYaUtiUkZ4ekZ2ZFhETy0yT1dVam5PSTg</guid><pubDate>Fri, 12 Jun 2026 00:13:59 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE81RjFMNTdfQVhlYTJ6OEVsS1RzTEtSbHdSbHlrV21jRG1uNmNZaTMxT0cwYWFMdG1GZ1pqbTNENHdZb20wbV9TYXNjNXFUMVB4QXJNeldhVFhiQzRzVDlUb184V0diblZvT2U3VFNwMNIBc0FVX3lxTE1zaFEzbzVPSndFMndPSXlUN3lpZXptU2hkTFFveGhEeU1NemFrSEs2bjFrYUU3UEN1VnlmQm5tMjhERkRRaHd5VTRZR2pWd2VGWFhkRHFiclplVDRYaUtiUkZ4ekZ2ZFhETy0yT1dVam5PSTg?oc=5" target="_blank"&gt;셀트리온 'HER2 다중항체 신약 전임상서 항암 효과 확인'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리한국&lt;/font&gt;</description><source url="https://daily.hankooki.com">데일리한국</source></item><item><title>동아ST·메타비아, ADA서 비만·MASH 후보물질 임상·전임상 데이터 공개 - PRESS9</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTE00TUNiZUlwb0ZBTUdRTFZqSnhaTFlJeFYyM2R6NEplTWV2QTk0TmpSRTZORVpDYUhiVlNFbGptM1pZQVRxVzVBZGZVZUJhM3gyYTdyTDhCQ1FTdVVFMkpOYVQ0bkxqUQ?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTE00TUNiZUlwb0ZBTUdRTFZqSnhaTFlJeFYyM2R6NEplTWV2QTk0TmpSRTZORVpDYUhiVlNFbGptM1pZQVRxVzVBZGZVZUJhM3gyYTdyTDhCQ1FTdVVFMkpOYVQ0bkxqUQ</guid><pubDate>Tue, 09 Jun 2026 02:16:09 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTE00TUNiZUlwb0ZBTUdRTFZqSnhaTFlJeFYyM2R6NEplTWV2QTk0TmpSRTZORVpDYUhiVlNFbGptM1pZQVRxVzVBZGZVZUJhM3gyYTdyTDhCQ1FTdVVFMkpOYVQ0bkxqUQ?oc=5" target="_blank"&gt;동아ST·메타비아, ADA서 비만·MASH 후보물질 임상·전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PRESS9&lt;/font&gt;</description><source url="https://www.press9.kr">PRESS9</source></item><item><title>[ADA 2026] 지투지바이오, 월1회 비만 전임상 데이터 "ADA 2026서 발표" - 파이낸스스코프</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTFBPS1RjT3cyeE5rcVFCWWVCVEcxNjkxazFTU1BBM2RaNVpTNFNyY2hYUHJkYnk2Ym1FZVdsbDNPZjF6UjJmbFh2T3k3bU1JY1R0cmZOYzljZ04yNnJCQjhXT3o0NDdwemt6aHc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTFBPS1RjT3cyeE5rcVFCWWVCVEcxNjkxazFTU1BBM2RaNVpTNFNyY2hYUHJkYnk2Ym1FZVdsbDNPZjF6UjJmbFh2T3k3bU1JY1R0cmZOYzljZ04yNnJCQjhXT3o0NDdwemt6aHc</guid><pubDate>Mon, 08 Jun 2026 04:35:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBPS1RjT3cyeE5rcVFCWWVCVEcxNjkxazFTU1BBM2RaNVpTNFNyY2hYUHJkYnk2Ym1FZVdsbDNPZjF6UjJmbFh2T3k3bU1JY1R0cmZOYzljZ04yNnJCQjhXT3o0NDdwemt6aHc?oc=5" target="_blank"&gt;[ADA 2026] 지투지바이오, 월1회 비만 전임상 데이터 "ADA 2026서 발표"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;파이낸스스코프&lt;/font&gt;</description><source url="https://www.finance-scope.com">파이낸스스코프</source></item><item><title>파미셀 동종 줄기세포, 중증 알코올성 간염 전임상서 지표 개선 가능성 - 팜이데일리</title><link>https://news.google.com/rss/articles/CBMibkFVX3lxTFBsM0UxLTFNSWx3NUJERDFIQkN6TGxVNEk5azlmUUtEX1RaQmEybHBocmdXd2Z1em5BaFQ5Vmo3TEotbk1YdG4ySGF3WnB6OVUweTZOalh2NUs2NnVSNm82RlotbGs3cjFBN0ZkNVF3?oc=5</link><guid isPermaLink="false">CBMibkFVX3lxTFBsM0UxLTFNSWx3NUJERDFIQkN6TGxVNEk5azlmUUtEX1RaQmEybHBocmdXd2Z1em5BaFQ5Vmo3TEotbk1YdG4ySGF3WnB6OVUweTZOalh2NUs2NnVSNm82RlotbGs3cjFBN0ZkNVF3</guid><pubDate>Thu, 28 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibkFVX3lxTFBsM0UxLTFNSWx3NUJERDFIQkN6TGxVNEk5azlmUUtEX1RaQmEybHBocmdXd2Z1em5BaFQ5Vmo3TEotbk1YdG4ySGF3WnB6OVUweTZOalh2NUs2NnVSNm82RlotbGs3cjFBN0ZkNVF3?oc=5" target="_blank"&gt;파미셀 동종 줄기세포, 중증 알코올성 간염 전임상서 지표 개선 가능성&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;팜이데일리&lt;/font&gt;</description><source url="https://pharm.edaily.co.kr">팜이데일리</source></item><item><title>바이젠셀, 교모세포종 파이프라인 'VC302' 전임상 연구결과 유럽암학회 발표 - 아시아경제</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTFB4TnNUT3UzNmZGbGF5Szkxc2kxSzhGa2F6Q2FCcXNXQjM0LW1jUHM2VHhBYXM5em03dDJiLWEwYzZ3TjdkcnJwQ3ExR2xUSmYzZzk5ZzY4b1BoT0U2ejJuVg?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTFB4TnNUT3UzNmZGbGF5Szkxc2kxSzhGa2F6Q2FCcXNXQjM0LW1jUHM2VHhBYXM5em03dDJiLWEwYzZ3TjdkcnJwQ3ExR2xUSmYzZzk5ZzY4b1BoT0U2ejJuVg</guid><pubDate>Mon, 08 Jun 2026 00:49:05 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFB4TnNUT3UzNmZGbGF5Szkxc2kxSzhGa2F6Q2FCcXNXQjM0LW1jUHM2VHhBYXM5em03dDJiLWEwYzZ3TjdkcnJwQ3ExR2xUSmYzZzk5ZzY4b1BoT0U2ejJuVg?oc=5" target="_blank"&gt;바이젠셀, 교모세포종 파이프라인 'VC302' 전임상 연구결과 유럽암학회 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;아시아경제&lt;/font&gt;</description><source url="https://www.asiae.co.kr">아시아경제</source></item><item><title>알테오젠, ALT-B4 피하주사 제형화 전임상 실험 결과 공개 - 주간한국</title><link>https://news.google.com/rss/articles/CBMicEFVX3lxTFBJcDlTR0FaendmeXNqanJNUGwyUEgzVFZwVEpfWnpCSmhxcWFNYlBTZTN6VnZjMC1mSW1udmktU3BYblROMW5PcVJsREdkRlYzak1lcEtSdlA0THV0dTA1cXN5eVlWdjlsUTlQS1hxQUXSAXRBVV95cUxOVTY1amcwZ3lxdEZocXZwM051eWtlOTB6LWx3QW5kSlJxQVp3WkdhQlJiSHhvYXYxT2NrY2xMX1lVSUpFTDd3VnRqdXhxdjJIbjN0ZUYwekh0dWI1bzU1aXlTZGhEdlR1eEFyZUFJLXlOVWtXQw?oc=5</link><guid isPermaLink="false">CBMicEFVX3lxTFBJcDlTR0FaendmeXNqanJNUGwyUEgzVFZwVEpfWnpCSmhxcWFNYlBTZTN6VnZjMC1mSW1udmktU3BYblROMW5PcVJsREdkRlYzak1lcEtSdlA0THV0dTA1cXN5eVlWdjlsUTlQS1hxQUXSAXRBVV95cUxOVTY1amcwZ3lxdEZocXZwM051eWtlOTB6LWx3QW5kSlJxQVp3WkdhQlJiSHhvYXYxT2NrY2xMX1lVSUpFTDd3VnRqdXhxdjJIbjN0ZUYwekh0dWI1bzU1aXlTZGhEdlR1eEFyZUFJLXlOVWtXQw</guid><pubDate>Wed, 10 Jun 2026 06:23:06 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMicEFVX3lxTFBJcDlTR0FaendmeXNqanJNUGwyUEgzVFZwVEpfWnpCSmhxcWFNYlBTZTN6VnZjMC1mSW1udmktU3BYblROMW5PcVJsREdkRlYzak1lcEtSdlA0THV0dTA1cXN5eVlWdjlsUTlQS1hxQUXSAXRBVV95cUxOVTY1amcwZ3lxdEZocXZwM051eWtlOTB6LWx3QW5kSlJxQVp3WkdhQlJiSHhvYXYxT2NrY2xMX1lVSUpFTDd3VnRqdXhxdjJIbjN0ZUYwekh0dWI1bzU1aXlTZGhEdlR1eEFyZUFJLXlOVWtXQw?oc=5" target="_blank"&gt;알테오젠, ALT-B4 피하주사 제형화 전임상 실험 결과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;주간한국&lt;/font&gt;</description><source url="https://weekly.hankooki.com">주간한국</source></item><item><title>대원제약, ADA서 4중 비만치료제 전임상 공개 - 데일리팜</title><link>https://news.google.com/rss/articles/CBMiYkFVX3lxTE00VW0wMUlHbzhpVTBVSlYzV2dIWmNWdVBOU0N5a0ptLVlXOW9LeVEtYl83VXVkNnN5MnhPU1JlbVctQzI5bHpNZmNQbXNFaW1Da1gwVVo4Mk1RajRubklQSnlR?oc=5</link><guid isPermaLink="false">CBMiYkFVX3lxTE00VW0wMUlHbzhpVTBVSlYzV2dIWmNWdVBOU0N5a0ptLVlXOW9LeVEtYl83VXVkNnN5MnhPU1JlbVctQzI5bHpNZmNQbXNFaW1Da1gwVVo4Mk1RajRubklQSnlR</guid><pubDate>Thu, 04 Jun 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTE00VW0wMUlHbzhpVTBVSlYzV2dIWmNWdVBOU0N5a0ptLVlXOW9LeVEtYl83VXVkNnN5MnhPU1JlbVctQzI5bHpNZmNQbXNFaW1Da1gwVVo4Mk1RajRubklQSnlR?oc=5" target="_blank"&gt;대원제약, ADA서 4중 비만치료제 전임상 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;데일리팜&lt;/font&gt;</description><source url="https://dailypharm.com">데일리팜</source></item><item><title>바이젠셀, 교모세포종 신약 'VC302' 전임상서 완전관해 100% - 머니투데이 - 머니투데이</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE4wcWFZUnBJZlNfNW50ZnptWlhCOHBoX3JhNmtMTTllUndmaXNSaVJTTUs2T1MxUk9Ec3p5ZjhxUzhwVFFPaVVmNi0zLXlUZVhXUUstbERUaEFSSDRQT1I0MXU0R2k3c3BRQ2fSAW9BVV95cUxObFg4UzJzcVRpSEZRQ09BU1VhX0lMY0hyZldTaktsQ0s3dUtJU3NkZ1lrMTBZU09QOEcwMElfU1RnVGZYMlFNQWM1QjZQVHl1TFBBbDZaT2lMR3J3VEZGWWdpUXMyNkR4SWxaelBJY1E?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE4wcWFZUnBJZlNfNW50ZnptWlhCOHBoX3JhNmtMTTllUndmaXNSaVJTTUs2T1MxUk9Ec3p5ZjhxUzhwVFFPaVVmNi0zLXlUZVhXUUstbERUaEFSSDRQT1I0MXU0R2k3c3BRQ2fSAW9BVV95cUxObFg4UzJzcVRpSEZRQ09BU1VhX0lMY0hyZldTaktsQ0s3dUtJU3NkZ1lrMTBZU09QOEcwMElfU1RnVGZYMlFNQWM1QjZQVHl1TFBBbDZaT2lMR3J3VEZGWWdpUXMyNkR4SWxaelBJY1E</guid><pubDate>Mon, 08 Jun 2026 00:53:07 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE4wcWFZUnBJZlNfNW50ZnptWlhCOHBoX3JhNmtMTTllUndmaXNSaVJTTUs2T1MxUk9Ec3p5ZjhxUzhwVFFPaVVmNi0zLXlUZVhXUUstbERUaEFSSDRQT1I0MXU0R2k3c3BRQ2fSAW9BVV95cUxObFg4UzJzcVRpSEZRQ09BU1VhX0lMY0hyZldTaktsQ0s3dUtJU3NkZ1lrMTBZU09QOEcwMElfU1RnVGZYMlFNQWM1QjZQVHl1TFBBbDZaT2lMR3J3VEZGWWdpUXMyNkR4SWxaelBJY1E?oc=5" target="_blank"&gt;바이젠셀, 교모세포종 신약 'VC302' 전임상서 완전관해 100% - 머니투데이&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;머니투데이&lt;/font&gt;</description><source url="https://www.mt.co.kr">머니투데이</source></item><item><title>알테오젠, ADC 피하주사 전임상 결과 공개 "ALT-B4로 흡수율·안전성 개선" - 파이낸셜뉴스</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE52Wm5pQVV1eUgwNkxNRGEwNzd4eDJvLWhtc2lEeFk5NmFqUnJjcElKZko0aFJ3Ymh6LVd6U1B5RHZTWm5VUllNVHZGMWstNUwxMGVvOW9na1JqQdIBXkFVX3lxTE9POGQ4bENHQ243LU1JVzNnbmxVVHpkdnFkQXB3d3lHNEVXUWZ5cmVBNHhQOFlLbUVZeWRkbzc1OGtKYjBacEdLLXZDRG1INEI4eDlQUGI5dlhwQ2lxamc?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE52Wm5pQVV1eUgwNkxNRGEwNzd4eDJvLWhtc2lEeFk5NmFqUnJjcElKZko0aFJ3Ymh6LVd6U1B5RHZTWm5VUllNVHZGMWstNUwxMGVvOW9na1JqQdIBXkFVX3lxTE9POGQ4bENHQ243LU1JVzNnbmxVVHpkdnFkQXB3d3lHNEVXUWZ5cmVBNHhQOFlLbUVZeWRkbzc1OGtKYjBacEdLLXZDRG1INEI4eDlQUGI5dlhwQ2lxamc</guid><pubDate>Wed, 10 Jun 2026 06:50:30 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE52Wm5pQVV1eUgwNkxNRGEwNzd4eDJvLWhtc2lEeFk5NmFqUnJjcElKZko0aFJ3Ymh6LVd6U1B5RHZTWm5VUllNVHZGMWstNUwxMGVvOW9na1JqQdIBXkFVX3lxTE9POGQ4bENHQ243LU1JVzNnbmxVVHpkdnFkQXB3d3lHNEVXUWZ5cmVBNHhQOFlLbUVZeWRkbzc1OGtKYjBacEdLLXZDRG1INEI4eDlQUGI5dlhwQ2lxamc?oc=5" target="_blank"&gt;알테오젠, ADC 피하주사 전임상 결과 공개 "ALT-B4로 흡수율·안전성 개선"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;파이낸셜뉴스&lt;/font&gt;</description><source url="https://www.fnnews.com">파이낸셜뉴스</source></item><item><title>프로티나, ADA서 장기 지속형 비만 치료 항체 전임상 데이터 공개 - 디지틀조선일보</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxPTGpaMHBCVE9vRmwtaDRGci1wVll6ME1fWXNra21lMEFPbG5FTmlTeVZSZGltM3dQQnlNT0k5N3V6ZGptSVpvUVR1SzNqa0RuY0lnaERYNWR2em02Ym9jcjl3am40RmNhSm5wVHRZTkcxRDJGb2FiSmU3XzJiR2J0Vjc1RkY0VzTSAXtBVV95cUxOQVJ1Z2tvMzZQOThRMGlPSk0waTlkbzlnYkxCX0M2T0ozSzVjLVNPQTZpbThXMzhkdGxwamYxMjZGXzd5b1gxMFdaWlJrMFhOWkVEd1ZKLTFKUE9aS2hrdVdrVzg1TXdka1ltQ0xHdWxvXzdDSmtlWDZGbzg?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxPTGpaMHBCVE9vRmwtaDRGci1wVll6ME1fWXNra21lMEFPbG5FTmlTeVZSZGltM3dQQnlNT0k5N3V6ZGptSVpvUVR1SzNqa0RuY0lnaERYNWR2em02Ym9jcjl3am40RmNhSm5wVHRZTkcxRDJGb2FiSmU3XzJiR2J0Vjc1RkY0VzTSAXtBVV95cUxOQVJ1Z2tvMzZQOThRMGlPSk0waTlkbzlnYkxCX0M2T0ozSzVjLVNPQTZpbThXMzhkdGxwamYxMjZGXzd5b1gxMFdaWlJrMFhOWkVEd1ZKLTFKUE9aS2hrdVdrVzg1TXdka1ltQ0xHdWxvXzdDSmtlWDZGbzg</guid><pubDate>Tue, 09 Jun 2026 02:23:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxPTGpaMHBCVE9vRmwtaDRGci1wVll6ME1fWXNra21lMEFPbG5FTmlTeVZSZGltM3dQQnlNT0k5N3V6ZGptSVpvUVR1SzNqa0RuY0lnaERYNWR2em02Ym9jcjl3am40RmNhSm5wVHRZTkcxRDJGb2FiSmU3XzJiR2J0Vjc1RkY0VzTSAXtBVV95cUxOQVJ1Z2tvMzZQOThRMGlPSk0waTlkbzlnYkxCX0M2T0ozSzVjLVNPQTZpbThXMzhkdGxwamYxMjZGXzd5b1gxMFdaWlJrMFhOWkVEd1ZKLTFKUE9aS2hrdVdrVzg1TXdka1ltQ0xHdWxvXzdDSmtlWDZGbzg?oc=5" target="_blank"&gt;프로티나, ADA서 장기 지속형 비만 치료 항체 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;디지틀조선일보&lt;/font&gt;</description><source url="https://digitalchosun.dizzo.com">디지틀조선일보</source></item><item><title>대원제약, 미국당뇨병학회서 4중 비만치료제 전임상 데이터 발표 - 메디포뉴스</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE0xOWZRT05sbnRKQ0gzcGVrYUlSaTVrOGJ0ekZydVYzWnlzY3kwVHBHMWJlQnNKWGZVM05EUGg4NXRtNUM4NmViMWFENUJnR3djQldwcTBYTnNrY1lqdDVOZEJia1Y?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE0xOWZRT05sbnRKQ0gzcGVrYUlSaTVrOGJ0ekZydVYzWnlzY3kwVHBHMWJlQnNKWGZVM05EUGg4NXRtNUM4NmViMWFENUJnR3djQldwcTBYTnNrY1lqdDVOZEJia1Y</guid><pubDate>Thu, 04 Jun 2026 00:50:15 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE0xOWZRT05sbnRKQ0gzcGVrYUlSaTVrOGJ0ekZydVYzWnlzY3kwVHBHMWJlQnNKWGZVM05EUGg4NXRtNUM4NmViMWFENUJnR3djQldwcTBYTnNrY1lqdDVOZEJia1Y?oc=5" target="_blank"&gt;대원제약, 미국당뇨병학회서 4중 비만치료제 전임상 데이터 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디포뉴스&lt;/font&gt;</description><source url="https://www.medifonews.com">메디포뉴스</source></item><item><title>지투지바이오, ADA서 비만치료제 전임상 데이터 공개 - 뉴스핌</title><link>https://news.google.com/rss/articles/CBMiXEFVX3lxTE00UTBEblNmRVdKSlU4MEcyaDNCSzIwU1dsdXBoWjhTam9VQ1VweTZJenU1VE5UWjFHRWJiNmRpQUZjaFdjcmRxekpQaW1CcUVoM0g4MUQ4aHVONkNM?oc=5</link><guid isPermaLink="false">CBMiXEFVX3lxTE00UTBEblNmRVdKSlU4MEcyaDNCSzIwU1dsdXBoWjhTam9VQ1VweTZJenU1VE5UWjFHRWJiNmRpQUZjaFdjcmRxekpQaW1CcUVoM0g4MUQ4aHVONkNM</guid><pubDate>Mon, 08 Jun 2026 04:55:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE00UTBEblNmRVdKSlU4MEcyaDNCSzIwU1dsdXBoWjhTam9VQ1VweTZJenU1VE5UWjFHRWJiNmRpQUZjaFdjcmRxekpQaW1CcUVoM0g4MUQ4aHVONkNM?oc=5" target="_blank"&gt;지투지바이오, ADA서 비만치료제 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스핌&lt;/font&gt;</description><source url="https://www.newspim.com">뉴스핌</source></item><item><title>올릭스, BBB 셔틀 적용 siRNA 전임상 성과 확보…"글로벌 수준 상회" - 네이트</title><link>https://news.google.com/rss/articles/CBMiU0FVX3lxTFB4dFBNTHJWTUM0X3JsV0hmMDN0cDlCaEFpT2F6dUpsMV9NZ3VGVlNNTnZsWlY0SmcwSGJCVnQ0eGx6WTMyUmFvaVdiaXlSSHFZRDVF?oc=5</link><guid isPermaLink="false">CBMiU0FVX3lxTFB4dFBNTHJWTUM0X3JsV0hmMDN0cDlCaEFpT2F6dUpsMV9NZ3VGVlNNTnZsWlY0SmcwSGJCVnQ0eGx6WTMyUmFvaVdiaXlSSHFZRDVF</guid><pubDate>Fri, 12 Jun 2026 07:39:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFB4dFBNTHJWTUM0X3JsV0hmMDN0cDlCaEFpT2F6dUpsMV9NZ3VGVlNNTnZsWlY0SmcwSGJCVnQ0eGx6WTMyUmFvaVdiaXlSSHFZRDVF?oc=5" target="_blank"&gt;올릭스, BBB 셔틀 적용 siRNA 전임상 성과 확보…"글로벌 수준 상회"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이트&lt;/font&gt;</description><source url="https://news.nate.com">네이트</source></item><item><title>대원제약, 美당뇨학회서 ‘비만 4중 작용제’ 전임상 결과 발표…“체중·혈당 개선 확인" - 조선비즈 - Chosunbiz</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxQMlQ3SFpRdmpzUU5jNDdnWVJoaklLNTBsUTh1ZFQxYnZ6NVJtcVgzRHRfMUZGdi1TN0dHb3pNMlRaSUtuUHJ2dUw2SzNXTG1aWHROWkFLLURQcXJWUEFkWHp4MWVnSkozSHBTSXVkSlR3V0tOMjA5WVo3X0RJZUlJLTJ1aVhoNk3SAZsBQVVfeXFMTnRFVXFHQ1JwX0s4c1NScVlERVVMU1J5a21QSUJDczExNGxZbkVsdUd3QU1mOVF5U3hxVjBzWWo5VnJQdGkybGVrMUFKQW8wbEV5TWE2eUZkeUdaa3o1V2FhZGt4QXdYeVY3UXJheFQ2OXppRmRrekwzQkcyeWFaVmxMb21mYmlhS1U3eUVSWVRNNjBZZFI2TGsydjA?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxQMlQ3SFpRdmpzUU5jNDdnWVJoaklLNTBsUTh1ZFQxYnZ6NVJtcVgzRHRfMUZGdi1TN0dHb3pNMlRaSUtuUHJ2dUw2SzNXTG1aWHROWkFLLURQcXJWUEFkWHp4MWVnSkozSHBTSXVkSlR3V0tOMjA5WVo3X0RJZUlJLTJ1aVhoNk3SAZsBQVVfeXFMTnRFVXFHQ1JwX0s4c1NScVlERVVMU1J5a21QSUJDczExNGxZbkVsdUd3QU1mOVF5U3hxVjBzWWo5VnJQdGkybGVrMUFKQW8wbEV5TWE2eUZkeUdaa3o1V2FhZGt4QXdYeVY3UXJheFQ2OXppRmRrekwzQkcyeWFaVmxMb21mYmlhS1U3eUVSWVRNNjBZZFI2TGsydjA</guid><pubDate>Thu, 04 Jun 2026 05:28:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxQMlQ3SFpRdmpzUU5jNDdnWVJoaklLNTBsUTh1ZFQxYnZ6NVJtcVgzRHRfMUZGdi1TN0dHb3pNMlRaSUtuUHJ2dUw2SzNXTG1aWHROWkFLLURQcXJWUEFkWHp4MWVnSkozSHBTSXVkSlR3V0tOMjA5WVo3X0RJZUlJLTJ1aVhoNk3SAZsBQVVfeXFMTnRFVXFHQ1JwX0s4c1NScVlERVVMU1J5a21QSUJDczExNGxZbkVsdUd3QU1mOVF5U3hxVjBzWWo5VnJQdGkybGVrMUFKQW8wbEV5TWE2eUZkeUdaa3o1V2FhZGt4QXdYeVY3UXJheFQ2OXppRmRrekwzQkcyeWFaVmxMb21mYmlhS1U3eUVSWVRNNjBZZFI2TGsydjA?oc=5" target="_blank"&gt;대원제약, 美당뇨학회서 ‘비만 4중 작용제’ 전임상 결과 발표…“체중·혈당 개선 확인" - 조선비즈&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Chosunbiz&lt;/font&gt;</description><source url="https://biz.chosun.com">Chosunbiz</source></item><item><title>올릭스, BBB 셔틀 적용 전임상서 '글로벌 수준 상회' 유전자 억제 입증…"실제 뇌 조직 내 확인" - 네이트</title><link>https://news.google.com/rss/articles/CBMiU0FVX3lxTFBscU9yM3VPdjJ1ME9CZy1tVEhaSi1RaTBRclZPUjdGQ0RRdldTQjFoVUUwR1h3SGJ4S29faEYxazFYdElpdjRsdXNCQ2R6U09BcF93?oc=5</link><guid isPermaLink="false">CBMiU0FVX3lxTFBscU9yM3VPdjJ1ME9CZy1tVEhaSi1RaTBRclZPUjdGQ0RRdldTQjFoVUUwR1h3SGJ4S29faEYxazFYdElpdjRsdXNCQ2R6U09BcF93</guid><pubDate>Fri, 12 Jun 2026 04:54:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTFBscU9yM3VPdjJ1ME9CZy1tVEhaSi1RaTBRclZPUjdGQ0RRdldTQjFoVUUwR1h3SGJ4S29faEYxazFYdElpdjRsdXNCQ2R6U09BcF93?oc=5" target="_blank"&gt;올릭스, BBB 셔틀 적용 전임상서 '글로벌 수준 상회' 유전자 억제 입증…"실제 뇌 조직 내 확인"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이트&lt;/font&gt;</description><source url="https://news.nate.com">네이트</source></item><item><title>지투지바이오, 美당뇨병학회서 한달 제형 비만약 전임상 데이터 공개 - 한국경제</title><link>https://news.google.com/rss/articles/CBMiWkFVX3lxTE4ybTRhZjg5dVNlQy14b0VIQWJVd1dwS2tqa25EbVVqODJFWklnbTNObThDT0ljLXoxc215UUNuMU4tZVZ2Um5CSFJkZzFnaDgtWEZ3QnpxdFF6Z9IBVEFVX3lxTE5SNHlNNnpyY0tBMHRaTGVwcG9DazZsUFlrbnFCS0NSQVZpbk9CMDhydHM0Vk14RXZRSEI4czVXRXRZRFlhTjNrb0VVQ28tV21KdTBLag?oc=5</link><guid isPermaLink="false">CBMiWkFVX3lxTE4ybTRhZjg5dVNlQy14b0VIQWJVd1dwS2tqa25EbVVqODJFWklnbTNObThDT0ljLXoxc215UUNuMU4tZVZ2Um5CSFJkZzFnaDgtWEZ3QnpxdFF6Z9IBVEFVX3lxTE5SNHlNNnpyY0tBMHRaTGVwcG9DazZsUFlrbnFCS0NSQVZpbk9CMDhydHM0Vk14RXZRSEI4czVXRXRZRFlhTjNrb0VVQ28tV21KdTBLag</guid><pubDate>Mon, 08 Jun 2026 06:26:12 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE4ybTRhZjg5dVNlQy14b0VIQWJVd1dwS2tqa25EbVVqODJFWklnbTNObThDT0ljLXoxc215UUNuMU4tZVZ2Um5CSFJkZzFnaDgtWEZ3QnpxdFF6Z9IBVEFVX3lxTE5SNHlNNnpyY0tBMHRaTGVwcG9DazZsUFlrbnFCS0NSQVZpbk9CMDhydHM0Vk14RXZRSEI4czVXRXRZRFlhTjNrb0VVQ28tV21KdTBLag?oc=5" target="_blank"&gt;지투지바이오, 美당뇨병학회서 한달 제형 비만약 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국경제&lt;/font&gt;</description><source url="https://www.hankyung.com">한국경제</source></item><item><title>대원제약 ‘4중 비만약’ 기대 과열…“인체 임상 지켜봐야” - 서울경제TV</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE9ra2Fna2ZVN2lHTDBCSnVCWDRYSTVJMkt5UFBPTl9Dc05OdlpxTTFyMEphb18wS0dKQUFTQnlpMWptM2pnU3p6WnNnRy1yd2pKaWN4YWk1MUtPVGd1N2wtQ1k5TF8?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE9ra2Fna2ZVN2lHTDBCSnVCWDRYSTVJMkt5UFBPTl9Dc05OdlpxTTFyMEphb18wS0dKQUFTQnlpMWptM2pnU3p6WnNnRy1yd2pKaWN4YWk1MUtPVGd1N2wtQ1k5TF8</guid><pubDate>Tue, 09 Jun 2026 08:34:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE9ra2Fna2ZVN2lHTDBCSnVCWDRYSTVJMkt5UFBPTl9Dc05OdlpxTTFyMEphb18wS0dKQUFTQnlpMWptM2pnU3p6WnNnRy1yd2pKaWN4YWk1MUtPVGd1N2wtQ1k5TF8?oc=5" target="_blank"&gt;대원제약 ‘4중 비만약’ 기대 과열…“인체 임상 지켜봐야”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제TV&lt;/font&gt;</description><source url="https://www.sentv.co.kr">서울경제TV</source></item><item><title>[ADA] 인벤티지랩, 월1회 위고비 전임상 공개…오리지널 대비 체중 감량 우위 - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE81ZnY3UlZ6bzhSSHltbnFMdHg4aDZpYmd1dTRScUZWajFNVWZ1LTRvRjR1OVYzTnRGbV9Nb0pRSHpJQVRqdjlLVmdPdkhrUm1Mb2R4YlpNZnFVTS1ocTZBd3RKelVaQnlvLWhTedIBcEFVX3lxTE9aMjB3QWxTTWlpVjZpZk5hME9RZWFMVUhreW5oSlR6NEhPZVNaeFFtTzdrd2xlMXVOYi03bFZzZnV1SENNZXhCNUxLRkVIdXh3RW40OFl6OHlaMl90R09Xb2FwamJPVFBsUGJsZG9wLWc?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE81ZnY3UlZ6bzhSSHltbnFMdHg4aDZpYmd1dTRScUZWajFNVWZ1LTRvRjR1OVYzTnRGbV9Nb0pRSHpJQVRqdjlLVmdPdkhrUm1Mb2R4YlpNZnFVTS1ocTZBd3RKelVaQnlvLWhTedIBcEFVX3lxTE9aMjB3QWxTTWlpVjZpZk5hME9RZWFMVUhreW5oSlR6NEhPZVNaeFFtTzdrd2xlMXVOYi03bFZzZnV1SENNZXhCNUxLRkVIdXh3RW40OFl6OHlaMl90R09Xb2FwamJPVFBsUGJsZG9wLWc</guid><pubDate>Mon, 08 Jun 2026 01:27:26 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE81ZnY3UlZ6bzhSSHltbnFMdHg4aDZpYmd1dTRScUZWajFNVWZ1LTRvRjR1OVYzTnRGbV9Nb0pRSHpJQVRqdjlLVmdPdkhrUm1Mb2R4YlpNZnFVTS1ocTZBd3RKelVaQnlvLWhTedIBcEFVX3lxTE9aMjB3QWxTTWlpVjZpZk5hME9RZWFMVUhreW5oSlR6NEhPZVNaeFFtTzdrd2xlMXVOYi03bFZzZnV1SENNZXhCNUxLRkVIdXh3RW40OFl6OHlaMl90R09Xb2FwamJPVFBsUGJsZG9wLWc?oc=5" target="_blank"&gt;[ADA] 인벤티지랩, 월1회 위고비 전임상 공개…오리지널 대비 체중 감량 우위&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>셀트리온 "다중항체 항암 신약, 전임상서 효과 확인" - 네이트</title><link>https://news.google.com/rss/articles/CBMieEFVX3lxTFBRTk1YWUlQVkNNdkNnN3NSWVRpdGRlRnNscmRlUHZHS2ZiWC1ubWtMUnU3VFN6c2RsVEtQRnV2UGhXN21DVlk4MnBhaUN2amVVZUc0NGkyNHNJeDBXWkdBWEdCd2F0elZkb3hMcFRjQXVvQUZSS2RfRg?oc=5</link><guid isPermaLink="false">CBMieEFVX3lxTFBRTk1YWUlQVkNNdkNnN3NSWVRpdGRlRnNscmRlUHZHS2ZiWC1ubWtMUnU3VFN6c2RsVEtQRnV2UGhXN21DVlk4MnBhaUN2amVVZUc0NGkyNHNJeDBXWkdBWEdCd2F0elZkb3hMcFRjQXVvQUZSS2RfRg</guid><pubDate>Fri, 12 Jun 2026 02:38:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMieEFVX3lxTFBRTk1YWUlQVkNNdkNnN3NSWVRpdGRlRnNscmRlUHZHS2ZiWC1ubWtMUnU3VFN6c2RsVEtQRnV2UGhXN21DVlk4MnBhaUN2amVVZUc0NGkyNHNJeDBXWkdBWEdCd2F0elZkb3hMcFRjQXVvQUZSS2RfRg?oc=5" target="_blank"&gt;셀트리온 "다중항체 항암 신약, 전임상서 효과 확인"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이트&lt;/font&gt;</description><source url="https://m.news.nate.com">네이트</source></item><item><title>올릭스, 뇌 질환 치료제 전임상 순항…BBB 통과 siRNA 유효성 입증 - 플레이포럼</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE9yY0FTSzRBalRONW5KVmxmYzR0WG1qY1JyaFhkRjJKUFpzMVB1OHNzd1N2WGR2OVhTTVE3NUxBYkhWYXFlcVFYbkNQX3JtOWs1bUlNb0lUZXhiUU5qcUhuRy1taWNYZi1zR3ZRQg?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE9yY0FTSzRBalRONW5KVmxmYzR0WG1qY1JyaFhkRjJKUFpzMVB1OHNzd1N2WGR2OVhTTVE3NUxBYkhWYXFlcVFYbkNQX3JtOWs1bUlNb0lUZXhiUU5qcUhuRy1taWNYZi1zR3ZRQg</guid><pubDate>Fri, 12 Jun 2026 08:38:23 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE9yY0FTSzRBalRONW5KVmxmYzR0WG1qY1JyaFhkRjJKUFpzMVB1OHNzd1N2WGR2OVhTTVE3NUxBYkhWYXFlcVFYbkNQX3JtOWs1bUlNb0lUZXhiUU5qcUhuRy1taWNYZi1zR3ZRQg?oc=5" target="_blank"&gt;올릭스, 뇌 질환 치료제 전임상 순항…BBB 통과 siRNA 유효성 입증&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;플레이포럼&lt;/font&gt;</description><source url="https://www.playforum.net">플레이포럼</source></item><item><title>대원제악, 4중 비만 치료제 전임상 발표 소식에 ‘상한가’ [Why 바이오] - 서울경제</title><link>https://news.google.com/rss/articles/CBMiUkFVX3lxTE81ZmVieUtHNGVYQ21wc2NHMElOX1NWVi1PQ2ZTNzNjSTdZR1JUblFRTjRrRUdkWjdfOHlDUTFCU0V1aC04LVBpYl9LNjhUN0Y4dGfSAVNBVV95cUxNVXQwMkVtWnhTTzVHNlpIbHh5QlNQMnNaa0RPQUljck5oUDZsRHBjNUpiN2daWm4zVm44V3VocW9BMml6QmdYdk0xV2lqZm02ek1rUQ?oc=5</link><guid isPermaLink="false">CBMiUkFVX3lxTE81ZmVieUtHNGVYQ21wc2NHMElOX1NWVi1PQ2ZTNzNjSTdZR1JUblFRTjRrRUdkWjdfOHlDUTFCU0V1aC04LVBpYl9LNjhUN0Y4dGfSAVNBVV95cUxNVXQwMkVtWnhTTzVHNlpIbHh5QlNQMnNaa0RPQUljck5oUDZsRHBjNUpiN2daWm4zVm44V3VocW9BMml6QmdYdk0xV2lqZm02ek1rUQ</guid><pubDate>Fri, 05 Jun 2026 02:21:02 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE81ZmVieUtHNGVYQ21wc2NHMElOX1NWVi1PQ2ZTNzNjSTdZR1JUblFRTjRrRUdkWjdfOHlDUTFCU0V1aC04LVBpYl9LNjhUN0Y4dGfSAVNBVV95cUxNVXQwMkVtWnhTTzVHNlpIbHh5QlNQMnNaa0RPQUljck5oUDZsRHBjNUpiN2daWm4zVm44V3VocW9BMml6QmdYdk0xV2lqZm02ek1rUQ?oc=5" target="_blank"&gt;대원제악, 4중 비만 치료제 전임상 발표 소식에 ‘상한가’ [Why 바이오]&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제&lt;/font&gt;</description><source url="https://www.sedaily.com">서울경제</source></item><item><title>에이비엘바이오, 이중항체 ADC 'ABL209' 전임상 데이터 국제무대서 공개 - PRESS9</title><link>https://news.google.com/rss/articles/CBMiZEFVX3lxTE1Fek5lUllPX3g0dUkzYktjWEJzVGRlLUV5SmlDMC1jQ2ZRSklGdEdoLVVyOTNOcUw2M0JHdVRMRUZBMlVTQm1nMzZMV2RsUDY2eTZBTThJTS1NUGlKQWtERTJBUTM?oc=5</link><guid isPermaLink="false">CBMiZEFVX3lxTE1Fek5lUllPX3g0dUkzYktjWEJzVGRlLUV5SmlDMC1jQ2ZRSklGdEdoLVVyOTNOcUw2M0JHdVRMRUZBMlVTQm1nMzZMV2RsUDY2eTZBTThJTS1NUGlKQWtERTJBUTM</guid><pubDate>Sun, 07 Jun 2026 23:47:48 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE1Fek5lUllPX3g0dUkzYktjWEJzVGRlLUV5SmlDMC1jQ2ZRSklGdEdoLVVyOTNOcUw2M0JHdVRMRUZBMlVTQm1nMzZMV2RsUDY2eTZBTThJTS1NUGlKQWtERTJBUTM?oc=5" target="_blank"&gt;에이비엘바이오, 이중항체 ADC 'ABL209' 전임상 데이터 국제무대서 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PRESS9&lt;/font&gt;</description><source url="http://www.press9.kr">PRESS9</source></item><item><title>대원제약, 미국당뇨병학회서 비만치료제 전임상 데이터 발표 - 후생신보</title><link>https://news.google.com/rss/articles/CBMiREFVX3lxTE9Id0t0b0tidjRCVGNkNnJXZmtmaEVYcDEtRGs1VmdpYlY2b2hDU25BU2wzbUZEX2R5UmZkM1RPSkVaU2Fw?oc=5</link><guid isPermaLink="false">CBMiREFVX3lxTE9Id0t0b0tidjRCVGNkNnJXZmtmaEVYcDEtRGs1VmdpYlY2b2hDU25BU2wzbUZEX2R5UmZkM1RPSkVaU2Fw</guid><pubDate>Thu, 04 Jun 2026 00:51:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiREFVX3lxTE9Id0t0b0tidjRCVGNkNnJXZmtmaEVYcDEtRGs1VmdpYlY2b2hDU25BU2wzbUZEX2R5UmZkM1RPSkVaU2Fw?oc=5" target="_blank"&gt;대원제약, 미국당뇨병학회서 비만치료제 전임상 데이터 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;후생신보&lt;/font&gt;</description><source url="http://www.whosaeng.com">후생신보</source></item><item><title>대원제약, 가스트린 결합 ‘4중 비만치료제’ 전임상서 효과성 공개 - 뉴스토마토</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTE50a0lURXVOUkQwUkhJR3k3dkprM1pzM3F4QVZBSTVSSnJwb25aaFZCa09ERnI2N2Z2MklPcFJPalB2Y0p3RFlsMlJJUDd1ZVhLQ0ZSTm93aXZpUTNsTnMzdw?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTE50a0lURXVOUkQwUkhJR3k3dkprM1pzM3F4QVZBSTVSSnJwb25aaFZCa09ERnI2N2Z2MklPcFJPalB2Y0p3RFlsMlJJUDd1ZVhLQ0ZSTm93aXZpUTNsTnMzdw</guid><pubDate>Fri, 05 Jun 2026 02:35:41 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE50a0lURXVOUkQwUkhJR3k3dkprM1pzM3F4QVZBSTVSSnJwb25aaFZCa09ERnI2N2Z2MklPcFJPalB2Y0p3RFlsMlJJUDd1ZVhLQ0ZSTm93aXZpUTNsTnMzdw?oc=5" target="_blank"&gt;대원제약, 가스트린 결합 ‘4중 비만치료제’ 전임상서 효과성 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스토마토&lt;/font&gt;</description><source url="https://www.newstomato.com">뉴스토마토</source></item><item><title>대웅제약, ‘TEAD1/2 저해제’ 전임상 결과 "AACR 발표" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTE9KZzlLVk5KRnltV0Y4bFg0ZVR1VmRsMGJTUUNVbjlFVF9aR0xNMFpQdnhjVlNlenM1Yjg3MU5ULVhzVkdxRXlpNnlwd3pTczhlSFc4SHVpbw?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTE9KZzlLVk5KRnltV0Y4bFg0ZVR1VmRsMGJTUUNVbjlFVF9aR0xNMFpQdnhjVlNlenM1Yjg3MU5ULVhzVkdxRXlpNnlwd3pTczhlSFc4SHVpbw</guid><pubDate>Fri, 22 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTE9KZzlLVk5KRnltV0Y4bFg0ZVR1VmRsMGJTUUNVbjlFVF9aR0xNMFpQdnhjVlNlenM1Yjg3MU5ULVhzVkdxRXlpNnlwd3pTczhlSFc4SHVpbw?oc=5" target="_blank"&gt;대웅제약, ‘TEAD1/2 저해제’ 전임상 결과 "AACR 발표"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>대원제약, 미국당뇨병학회(ADA)서 4중 비만치료제 전임상 데이터 발표 - 한국의약통신</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE9HTHNpczU4NXpHQTBtTlVoTUdGVnJPc3AwYmR0LVluYTF3NHZ2bWpOVGJrSjlVNUUyZk4zcjFoMUUwWkRPSGVDTHRkNVpoTFVHbmh0WWt3bUxSaUdEQnJWNnVfV0pyNjU0WVJz?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE9HTHNpczU4NXpHQTBtTlVoTUdGVnJPc3AwYmR0LVluYTF3NHZ2bWpOVGJrSjlVNUUyZk4zcjFoMUUwWkRPSGVDTHRkNVpoTFVHbmh0WWt3bUxSaUdEQnJWNnVfV0pyNjU0WVJz</guid><pubDate>Thu, 04 Jun 2026 00:33:41 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE9HTHNpczU4NXpHQTBtTlVoTUdGVnJPc3AwYmR0LVluYTF3NHZ2bWpOVGJrSjlVNUUyZk4zcjFoMUUwWkRPSGVDTHRkNVpoTFVHbmh0WWt3bUxSaUdEQnJWNnVfV0pyNjU0WVJz?oc=5" target="_blank"&gt;대원제약, 미국당뇨병학회(ADA)서 4중 비만치료제 전임상 데이터 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국의약통신&lt;/font&gt;</description><source url="https://www.kmpnews.co.kr">한국의약통신</source></item><item><title>에스티큐브, AACR서 넬마스토바트 병용 전임상 결과 발표 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFBNbk5XUms0VFROYzkwemg2SEw2a2NvX1BaaVZpUjk4WW4xVjByY3pLQXNmcHhpWnJrc2poYUkxVTNlSTVGZFFCSEFyS3ZwcFBpQTJoNTNWdEVlcjBPQWg0SF8wZ0RkaVJueks4?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFBNbk5XUms0VFROYzkwemg2SEw2a2NvX1BaaVZpUjk4WW4xVjByY3pLQXNmcHhpWnJrc2poYUkxVTNlSTVGZFFCSEFyS3ZwcFBpQTJoNTNWdEVlcjBPQWg0SF8wZ0RkaVJueks4</guid><pubDate>Wed, 22 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFBNbk5XUms0VFROYzkwemg2SEw2a2NvX1BaaVZpUjk4WW4xVjByY3pLQXNmcHhpWnJrc2poYUkxVTNlSTVGZFFCSEFyS3ZwcFBpQTJoNTNWdEVlcjBPQWg0SF8wZ0RkaVJueks4?oc=5" target="_blank"&gt;에스티큐브, AACR서 넬마스토바트 병용 전임상 결과 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>셀트리온, 차세대 면역항암제 전임상 청신호…"HER2 고형암 대상 효능·확장 가능성 확인" - 네이트</title><link>https://news.google.com/rss/articles/CBMiU0FVX3lxTE9vTmM4VVctdndtYjBUV1ZoZVFaNUFVVzR5U0s3UEpVNnhtOV9SenVMZG5iZ2pDUXhMZHZJb3NCc3VlQy0xVzVySGx5WjZ1RDVDcjBV?oc=5</link><guid isPermaLink="false">CBMiU0FVX3lxTE9vTmM4VVctdndtYjBUV1ZoZVFaNUFVVzR5U0s3UEpVNnhtOV9SenVMZG5iZ2pDUXhMZHZJb3NCc3VlQy0xVzVySGx5WjZ1RDVDcjBV</guid><pubDate>Fri, 12 Jun 2026 01:44:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE9vTmM4VVctdndtYjBUV1ZoZVFaNUFVVzR5U0s3UEpVNnhtOV9SenVMZG5iZ2pDUXhMZHZJb3NCc3VlQy0xVzVySGx5WjZ1RDVDcjBV?oc=5" target="_blank"&gt;셀트리온, 차세대 면역항암제 전임상 청신호…"HER2 고형암 대상 효능·확장 가능성 확인"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이트&lt;/font&gt;</description><source url="https://news.nate.com">네이트</source></item><item><title>대원제약, 4중 비만치료제 전임상서 체중 50% 감소 확인 - 아시아경제</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTE9adUU2ajBMZ1J5SVNwUW92a0ozMTdHQm1KV0lON1NudU9JeEVNY0Q3T0tRQmZxbG9UVkxVanl6cGFLN1dpN2dFZl9tT0MwMTFLTW0xMWo1LUVEUDYwaThvcg?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTE9adUU2ajBMZ1J5SVNwUW92a0ozMTdHQm1KV0lON1NudU9JeEVNY0Q3T0tRQmZxbG9UVkxVanl6cGFLN1dpN2dFZl9tT0MwMTFLTW0xMWo1LUVEUDYwaThvcg</guid><pubDate>Thu, 04 Jun 2026 00:15:13 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTE9adUU2ajBMZ1J5SVNwUW92a0ozMTdHQm1KV0lON1NudU9JeEVNY0Q3T0tRQmZxbG9UVkxVanl6cGFLN1dpN2dFZl9tT0MwMTFLTW0xMWo1LUVEUDYwaThvcg?oc=5" target="_blank"&gt;대원제약, 4중 비만치료제 전임상서 체중 50% 감소 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;아시아경제&lt;/font&gt;</description><source url="https://www.asiae.co.kr">아시아경제</source></item><item><title>[AACR] 한미약품, AACR 2026서 'STING mRNA' 전임상 결과 주목 - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTFA4SEhVbEZIQXFvU0NwOHZMc0RkTk8tMlNTVnpUUVlWS1hpMjEyZVVONmRDN3lPSjRTeXpaZlJfWFZpTU9jWHY1Z2c2MTc4eWg4d0RNNWtCRzFQZGkxMkZrWWx5MmFpZGtxMGNz?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTFA4SEhVbEZIQXFvU0NwOHZMc0RkTk8tMlNTVnpUUVlWS1hpMjEyZVVONmRDN3lPSjRTeXpaZlJfWFZpTU9jWHY1Z2c2MTc4eWg4d0RNNWtCRzFQZGkxMkZrWWx5MmFpZGtxMGNz</guid><pubDate>Thu, 23 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTFA4SEhVbEZIQXFvU0NwOHZMc0RkTk8tMlNTVnpUUVlWS1hpMjEyZVVONmRDN3lPSjRTeXpaZlJfWFZpTU9jWHY1Z2c2MTc4eWg4d0RNNWtCRzFQZGkxMkZrWWx5MmFpZGtxMGNz?oc=5" target="_blank"&gt;[AACR] 한미약품, AACR 2026서 'STING mRNA' 전임상 결과 주목&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>셀트리온, HER2 다중항체 'CT-P72' 전임상 성과…차세대 항암 전략 가속 - 네이트</title><link>https://news.google.com/rss/articles/CBMiU0FVX3lxTE1TQWp4ejFBeDFBYm1va0E3RERHS3NEdm5lU3c5ck9DOHJFRkdkc1ZiOUxyRWNWcDZQR2dKRWsyX3g5U2I5MEV4MGJqenZyR1ZwM21R?oc=5</link><guid isPermaLink="false">CBMiU0FVX3lxTE1TQWp4ejFBeDFBYm1va0E3RERHS3NEdm5lU3c5ck9DOHJFRkdkc1ZiOUxyRWNWcDZQR2dKRWsyX3g5U2I5MEV4MGJqenZyR1ZwM21R</guid><pubDate>Sat, 13 Jun 2026 00:01:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE1TQWp4ejFBeDFBYm1va0E3RERHS3NEdm5lU3c5ck9DOHJFRkdkc1ZiOUxyRWNWcDZQR2dKRWsyX3g5U2I5MEV4MGJqenZyR1ZwM21R?oc=5" target="_blank"&gt;셀트리온, HER2 다중항체 'CT-P72' 전임상 성과…차세대 항암 전략 가속&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이트&lt;/font&gt;</description><source url="https://news.nate.com">네이트</source></item><item><title>[AACR] HLB 베리스모 KIR-CAR 플랫폼 '고형암 전임상서 유효성 입증' - 히트뉴스</title><link>https://news.google.com/rss/articles/CBMia0FVX3lxTE5sa2FHMnBkRW8wZlJVMjZOemxVbExwOExJNk4xNVl0eERSZTExcGNUMTJTMloxMmVVbUcwS29aNkRiRnYxOHEtcnBUb3FsOHJ0aVc5WnNnTG1XNE91LUprVUItUWtwX0tTY0Zr?oc=5</link><guid isPermaLink="false">CBMia0FVX3lxTE5sa2FHMnBkRW8wZlJVMjZOemxVbExwOExJNk4xNVl0eERSZTExcGNUMTJTMloxMmVVbUcwS29aNkRiRnYxOHEtcnBUb3FsOHJ0aVc5WnNnTG1XNE91LUprVUItUWtwX0tTY0Zr</guid><pubDate>Thu, 23 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE5sa2FHMnBkRW8wZlJVMjZOemxVbExwOExJNk4xNVl0eERSZTExcGNUMTJTMloxMmVVbUcwS29aNkRiRnYxOHEtcnBUb3FsOHJ0aVc5WnNnTG1XNE91LUprVUItUWtwX0tTY0Zr?oc=5" target="_blank"&gt;[AACR] HLB 베리스모 KIR-CAR 플랫폼 '고형암 전임상서 유효성 입증'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;히트뉴스&lt;/font&gt;</description><source url="https://www.hitnews.co.kr">히트뉴스</source></item><item><title>코오롱생명과학 KLS-3021, 삼중음성유방암 전임상서 항암효과 확인 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5FRUZTcEo0VGl6bENLU0tkQnBJeGdOS1NXMkNUTjUtOHp6YlpZOFNFSmhIZGdUMjBNeVF3MENHWnVaODFTSTVDdWIyVFE5bUtHbnIyUGFUbjlrWEN0ck9vaEJnS1pzY2pCVlZNcQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5FRUZTcEo0VGl6bENLU0tkQnBJeGdOS1NXMkNUTjUtOHp6YlpZOFNFSmhIZGdUMjBNeVF3MENHWnVaODFTSTVDdWIyVFE5bUtHbnIyUGFUbjlrWEN0ck9vaEJnS1pzY2pCVlZNcQ</guid><pubDate>Mon, 18 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5FRUZTcEo0VGl6bENLU0tkQnBJeGdOS1NXMkNUTjUtOHp6YlpZOFNFSmhIZGdUMjBNeVF3MENHWnVaODFTSTVDdWIyVFE5bUtHbnIyUGFUbjlrWEN0ck9vaEJnS1pzY2pCVlZNcQ?oc=5" target="_blank"&gt;코오롱생명과학 KLS-3021, 삼중음성유방암 전임상서 항암효과 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>알테오젠, BD와 디바이스 결합 '대용량SC' 전임상 "공개" - 바이오스펙테이터</title><link>https://news.google.com/rss/articles/CBMiV0FVX3lxTFAzdkk2WVotVXZ6Y2UyOThwVkFDRHdlTHRZSkdaVkdROU82eUIyOUl3blQ1THlrTl9HN2RVVDE3WXdoenVCSkpKeVg3WngyWXRJWmZVUnRDSQ?oc=5</link><guid isPermaLink="false">CBMiV0FVX3lxTFAzdkk2WVotVXZ6Y2UyOThwVkFDRHdlTHRZSkdaVkdROU82eUIyOUl3blQ1THlrTl9HN2RVVDE3WXdoenVCSkpKeVg3WngyWXRJWmZVUnRDSQ</guid><pubDate>Tue, 26 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFAzdkk2WVotVXZ6Y2UyOThwVkFDRHdlTHRZSkdaVkdROU82eUIyOUl3blQ1THlrTl9HN2RVVDE3WXdoenVCSkpKeVg3WngyWXRJWmZVUnRDSQ?oc=5" target="_blank"&gt;알테오젠, BD와 디바이스 결합 '대용량SC' 전임상 "공개"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;바이오스펙테이터&lt;/font&gt;</description><source url="https://www.biospectator.com">바이오스펙테이터</source></item><item><title>삼성바이오에피스, 美 암학회서 '1호 신약' 전임상 첫 공개 - v.daum.net</title><link>https://news.google.com/rss/articles/CBMiT0FVX3lxTE5fWTBtR1RyUUxTVmdDZkJtYjdZUHVYb09jTkRpTy1iTVlfbWV2OHZlbk9TWW9hcVF0cGVGTVJvalVKc0pueC1WVl9VaTlaalU?oc=5</link><guid isPermaLink="false">CBMiT0FVX3lxTE5fWTBtR1RyUUxTVmdDZkJtYjdZUHVYb09jTkRpTy1iTVlfbWV2OHZlbk9TWW9hcVF0cGVGTVJvalVKc0pueC1WVl9VaTlaalU</guid><pubDate>Tue, 21 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiT0FVX3lxTE5fWTBtR1RyUUxTVmdDZkJtYjdZUHVYb09jTkRpTy1iTVlfbWV2OHZlbk9TWW9hcVF0cGVGTVJvalVKc0pueC1WVl9VaTlaalU?oc=5" target="_blank"&gt;삼성바이오에피스, 美 암학회서 '1호 신약' 전임상 첫 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;v.daum.net&lt;/font&gt;</description><source url="https://v.daum.net">v.daum.net</source></item><item><title>알테오젠, 美 파트너사와 대용량 피하주사 전임상 공개…“약물 전달 개선 확인” - 조선비즈 - Chosunbiz</title><link>https://news.google.com/rss/articles/CBMihwFBVV95cUxOSFRHbmxiR0pUOXdDLUxhOG1lVU50SkFQVTRJaHAtVWtZS3R4YUFMdXNBYzR3QWVZREhWNHVGNTIzcFYwRk52bFZZTjNZVERIZHNBazFrT3ktUUlaNk5GOHR1c0RFaXZOQmZORF9SX0M2YVVfUXdHUHM0bkx3QnpUX2M0eUVlLVnSAZsBQVVfeXFMUHFHN0ZQY09yZTgxb3BEaWFKQjJkNG15SkhBc0kzVEZEalN5ekJjVldUSGkydU9oQk1Xd0hITVZLY0w1Ym5GQkRWWXQ4MlBqZkxnYjJ6ZUNRTlY1Y2tGQm9xS1N6MjVYbE1TUUIzTEktbDRYNkpWRWdEQm1GM29aWlhmQmY1VjZWZmJEMExkQlBvZERVbmxJU3RBUjg?oc=5</link><guid isPermaLink="false">CBMihwFBVV95cUxOSFRHbmxiR0pUOXdDLUxhOG1lVU50SkFQVTRJaHAtVWtZS3R4YUFMdXNBYzR3QWVZREhWNHVGNTIzcFYwRk52bFZZTjNZVERIZHNBazFrT3ktUUlaNk5GOHR1c0RFaXZOQmZORF9SX0M2YVVfUXdHUHM0bkx3QnpUX2M0eUVlLVnSAZsBQVVfeXFMUHFHN0ZQY09yZTgxb3BEaWFKQjJkNG15SkhBc0kzVEZEalN5ekJjVldUSGkydU9oQk1Xd0hITVZLY0w1Ym5GQkRWWXQ4MlBqZkxnYjJ6ZUNRTlY1Y2tGQm9xS1N6MjVYbE1TUUIzTEktbDRYNkpWRWdEQm1GM29aWlhmQmY1VjZWZmJEMExkQlBvZERVbmxJU3RBUjg</guid><pubDate>Tue, 26 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMihwFBVV95cUxOSFRHbmxiR0pUOXdDLUxhOG1lVU50SkFQVTRJaHAtVWtZS3R4YUFMdXNBYzR3QWVZREhWNHVGNTIzcFYwRk52bFZZTjNZVERIZHNBazFrT3ktUUlaNk5GOHR1c0RFaXZOQmZORF9SX0M2YVVfUXdHUHM0bkx3QnpUX2M0eUVlLVnSAZsBQVVfeXFMUHFHN0ZQY09yZTgxb3BEaWFKQjJkNG15SkhBc0kzVEZEalN5ekJjVldUSGkydU9oQk1Xd0hITVZLY0w1Ym5GQkRWWXQ4MlBqZkxnYjJ6ZUNRTlY1Y2tGQm9xS1N6MjVYbE1TUUIzTEktbDRYNkpWRWdEQm1GM29aWlhmQmY1VjZWZmJEMExkQlBvZERVbmxJU3RBUjg?oc=5" target="_blank"&gt;알테오젠, 美 파트너사와 대용량 피하주사 전임상 공개…“약물 전달 개선 확인” - 조선비즈&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;Chosunbiz&lt;/font&gt;</description><source url="https://biz.chosun.com">Chosunbiz</source></item><item><title>[특징주] 대원제약, '4중 비만치료제 전임상 발표' 소식에 '上' - 뉴스드림</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE5NUDZ3QzA4cXRiY0JmOHFIN1oxZFYwancwVjJQU3ZGN2s4T0xpNEpYb010UzlTQ2lzQVZTb0gwcFZfUUZWRGVpM0R1dnpDTXo4SnNPMVZBNXBxNTRNMm5WcXo4ZjVwY0pZUFHSAW5BVV95cUxQbFNWdEJEN1NMUzlpTWJNX1dyTDk5aVFEaDEzQjhlamVtZ1dlSEFBMlAzbXRsNFVnZ1NpRmM2aVp1eUpxS2doMUZRd1BSTjJDX1Y5RTVuSHpqNXl6TmVTNkxaUy0wVlhXM0ZVWDNzdw?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE5NUDZ3QzA4cXRiY0JmOHFIN1oxZFYwancwVjJQU3ZGN2s4T0xpNEpYb010UzlTQ2lzQVZTb0gwcFZfUUZWRGVpM0R1dnpDTXo4SnNPMVZBNXBxNTRNMm5WcXo4ZjVwY0pZUFHSAW5BVV95cUxQbFNWdEJEN1NMUzlpTWJNX1dyTDk5aVFEaDEzQjhlamVtZ1dlSEFBMlAzbXRsNFVnZ1NpRmM2aVp1eUpxS2doMUZRd1BSTjJDX1Y5RTVuSHpqNXl6TmVTNkxaUy0wVlhXM0ZVWDNzdw</guid><pubDate>Fri, 05 Jun 2026 00:36:45 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE5NUDZ3QzA4cXRiY0JmOHFIN1oxZFYwancwVjJQU3ZGN2s4T0xpNEpYb010UzlTQ2lzQVZTb0gwcFZfUUZWRGVpM0R1dnpDTXo4SnNPMVZBNXBxNTRNMm5WcXo4ZjVwY0pZUFHSAW5BVV95cUxQbFNWdEJEN1NMUzlpTWJNX1dyTDk5aVFEaDEzQjhlamVtZ1dlSEFBMlAzbXRsNFVnZ1NpRmM2aVp1eUpxS2doMUZRd1BSTjJDX1Y5RTVuSHpqNXl6TmVTNkxaUy0wVlhXM0ZVWDNzdw?oc=5" target="_blank"&gt;[특징주] 대원제약, '4중 비만치료제 전임상 발표' 소식에 '上'&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스드림&lt;/font&gt;</description><source url="http://www.newsdream.kr">뉴스드림</source></item><item><title>유한양행 개발 비만치료제, 3분기 전임상...내년말 1상 개시 - 메디소비자뉴스</title><link>https://news.google.com/rss/articles/CBMickFVX3lxTE1OdUx4MlpndkpyU2ZRSzFaNWZOM0ZNVHc1MlpjYlRVY1A4eG9GNk1QeVlOYkFkb2JIZ1dvTnBHaXJVcTlwbXJya3FQbnNfS0trZzVsV0tudzBaWWdLaHNuTVZMUDRLbzRJREd5ZkNNUEEyQdIBdkFVX3lxTE1YZ0dERF9KTVdFMUh3S1R5QnRkaUwxY0gzX2g0alBvYjk2MVllbUpvdlNRSUMwLThnNVZYSHJNRldBc1hmTkhRRTdtbnFETEd3ZkhxVERzajJwbVNJRkdBLWF4QW9EMnhLUXI1WTdraWlIWUQ2aVE?oc=5</link><guid isPermaLink="false">CBMickFVX3lxTE1OdUx4MlpndkpyU2ZRSzFaNWZOM0ZNVHc1MlpjYlRVY1A4eG9GNk1QeVlOYkFkb2JIZ1dvTnBHaXJVcTlwbXJya3FQbnNfS0trZzVsV0tudzBaWWdLaHNuTVZMUDRLbzRJREd5ZkNNUEEyQdIBdkFVX3lxTE1YZ0dERF9KTVdFMUh3S1R5QnRkaUwxY0gzX2g0alBvYjk2MVllbUpvdlNRSUMwLThnNVZYSHJNRldBc1hmTkhRRTdtbnFETEd3ZkhxVERzajJwbVNJRkdBLWF4QW9EMnhLUXI1WTdraWlIWUQ2aVE</guid><pubDate>Thu, 28 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMickFVX3lxTE1OdUx4MlpndkpyU2ZRSzFaNWZOM0ZNVHc1MlpjYlRVY1A4eG9GNk1QeVlOYkFkb2JIZ1dvTnBHaXJVcTlwbXJya3FQbnNfS0trZzVsV0tudzBaWWdLaHNuTVZMUDRLbzRJREd5ZkNNUEEyQdIBdkFVX3lxTE1YZ0dERF9KTVdFMUh3S1R5QnRkaUwxY0gzX2g0alBvYjk2MVllbUpvdlNRSUMwLThnNVZYSHJNRldBc1hmTkhRRTdtbnFETEd3ZkhxVERzajJwbVNJRkdBLWF4QW9EMnhLUXI1WTdraWlIWUQ2aVE?oc=5" target="_blank"&gt;유한양행 개발 비만치료제, 3분기 전임상...내년말 1상 개시&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디소비자뉴스&lt;/font&gt;</description><source url="http://www.medisobizanews.com">메디소비자뉴스</source></item><item><title>대원제약, 미국당뇨병학회서 4중 비만치료제 전임상 데이터 발표 - 뉴스1</title><link>https://news.google.com/rss/articles/CBMiYEFVX3lxTFBreEJIOWhteEhwT0FjNUVlX012R29IQk1wbXhGanRqSHljUnVCQlFSQWNxVFExZ2wxZ0hLenVvTG9iNzNOcHRiTFJLbHgyZzktcm9DYTMtczVJbF9MX09iUQ?oc=5</link><guid isPermaLink="false">CBMiYEFVX3lxTFBreEJIOWhteEhwT0FjNUVlX012R29IQk1wbXhGanRqSHljUnVCQlFSQWNxVFExZ2wxZ0hLenVvTG9iNzNOcHRiTFJLbHgyZzktcm9DYTMtczVJbF9MX09iUQ</guid><pubDate>Thu, 04 Jun 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYEFVX3lxTFBreEJIOWhteEhwT0FjNUVlX012R29IQk1wbXhGanRqSHljUnVCQlFSQWNxVFExZ2wxZ0hLenVvTG9iNzNOcHRiTFJLbHgyZzktcm9DYTMtczVJbF9MX09iUQ?oc=5" target="_blank"&gt;대원제약, 미국당뇨병학회서 4중 비만치료제 전임상 데이터 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;뉴스1&lt;/font&gt;</description><source url="https://www.news1.kr">뉴스1</source></item><item><title>대원제약, ‘4중 비만 치료제’ 전임상 데이터 공개 - 서울경제</title><link>https://news.google.com/rss/articles/CBMiUkFVX3lxTE9leVRybFpwZWxuUHlmMGxrZmE2Zkh0cmhvbEZDQVVuSXpRLXl5VFBqRFpsa2hZUG0xQ1QzRUNCejZ5amoxZy1TRHBXa3RDQ09nWXfSAVNBVV95cUxOcVNlS1NzcmVMSFZLTHk4Nk9vSklEVE1aLVlaTVl3azdOSVZ6d3dDSDI1N0J0NjFaZ1lBcEdfRWxtTjduZlBYTnRldW54N2VtRXZKWQ?oc=5</link><guid isPermaLink="false">CBMiUkFVX3lxTE9leVRybFpwZWxuUHlmMGxrZmE2Zkh0cmhvbEZDQVVuSXpRLXl5VFBqRFpsa2hZUG0xQ1QzRUNCejZ5amoxZy1TRHBXa3RDQ09nWXfSAVNBVV95cUxOcVNlS1NzcmVMSFZLTHk4Nk9vSklEVE1aLVlaTVl3azdOSVZ6d3dDSDI1N0J0NjFaZ1lBcEdfRWxtTjduZlBYTnRldW54N2VtRXZKWQ</guid><pubDate>Thu, 04 Jun 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE9leVRybFpwZWxuUHlmMGxrZmE2Zkh0cmhvbEZDQVVuSXpRLXl5VFBqRFpsa2hZUG0xQ1QzRUNCejZ5amoxZy1TRHBXa3RDQ09nWXfSAVNBVV95cUxOcVNlS1NzcmVMSFZLTHk4Nk9vSklEVE1aLVlaTVl3azdOSVZ6d3dDSDI1N0J0NjFaZ1lBcEdfRWxtTjduZlBYTnRldW54N2VtRXZKWQ?oc=5" target="_blank"&gt;대원제약, ‘4중 비만 치료제’ 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;서울경제&lt;/font&gt;</description><source url="https://www.sedaily.com">서울경제</source></item><item><title>K-AI 신약개발 사업 본격화, 전임상–임상 AI 연계 플랫폼 구축 - 의약뉴스</title><link>https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBHZWNnN19PZFkwSnFULVF3ajkwVDFrRzRRcGJNb2lOV05IUUVncGpQMHAyVjEyQzZ2RTBMT1RYeW1jR1BVODhVNGx3aC1tNHhTdEoyY04tS3owTkJHMk83SFZsbEZkWmc?oc=5</link><guid isPermaLink="false">CBMiZ0FVX3lxTFBHZWNnN19PZFkwSnFULVF3ajkwVDFrRzRRcGJNb2lOV05IUUVncGpQMHAyVjEyQzZ2RTBMT1RYeW1jR1BVODhVNGx3aC1tNHhTdEoyY04tS3owTkJHMk83SFZsbEZkWmc</guid><pubDate>Thu, 22 Jan 2026 08:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTFBHZWNnN19PZFkwSnFULVF3ajkwVDFrRzRRcGJNb2lOV05IUUVncGpQMHAyVjEyQzZ2RTBMT1RYeW1jR1BVODhVNGx3aC1tNHhTdEoyY04tS3owTkJHMk83SFZsbEZkWmc?oc=5" target="_blank"&gt;K-AI 신약개발 사업 본격화, 전임상–임상 AI 연계 플랫폼 구축&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;의약뉴스&lt;/font&gt;</description><source url="http://www.newsmp.com">의약뉴스</source></item><item><title>카나프테라퓨틱스, 황반변성 치료물질 'KNP-301' 전임상 결과 공개 - 청년의사</title><link>https://news.google.com/rss/articles/CBMib0FVX3lxTE1VZm5iNWQ3VmRiS29fRlg4X3JZRmVMRVFaVnhTalZxTmd1ZlRLaHdJSWFZbzJPVWFySVg3RUNUUG56TWRvU3Q3bGhZWDNBSVoxS0NueTAxTVVBckJRdnRJRWk4Q25SMmxoREpIejNsb9IBc0FVX3lxTE44M25BeHhvT0c2bjd4SDdpS1BZSzF1VzdZOEtyS1AwSUVzWWM2YlpjVEhvaGZPQ2hPSnpvVTM0LTM3S2xNdkJoZjhDUWZhUGhPV2JubjRTaVNDUDRmVUMzeExOUFJTQ1E4RWZHaENoU1k5cmM?oc=5</link><guid isPermaLink="false">CBMib0FVX3lxTE1VZm5iNWQ3VmRiS29fRlg4X3JZRmVMRVFaVnhTalZxTmd1ZlRLaHdJSWFZbzJPVWFySVg3RUNUUG56TWRvU3Q3bGhZWDNBSVoxS0NueTAxTVVBckJRdnRJRWk4Q25SMmxoREpIejNsb9IBc0FVX3lxTE44M25BeHhvT0c2bjd4SDdpS1BZSzF1VzdZOEtyS1AwSUVzWWM2YlpjVEhvaGZPQ2hPSnpvVTM0LTM3S2xNdkJoZjhDUWZhUGhPV2JubjRTaVNDUDRmVUMzeExOUFJTQ1E4RWZHaENoU1k5cmM</guid><pubDate>Wed, 29 Apr 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMib0FVX3lxTE1VZm5iNWQ3VmRiS29fRlg4X3JZRmVMRVFaVnhTalZxTmd1ZlRLaHdJSWFZbzJPVWFySVg3RUNUUG56TWRvU3Q3bGhZWDNBSVoxS0NueTAxTVVBckJRdnRJRWk4Q25SMmxoREpIejNsb9IBc0FVX3lxTE44M25BeHhvT0c2bjd4SDdpS1BZSzF1VzdZOEtyS1AwSUVzWWM2YlpjVEhvaGZPQ2hPSnpvVTM0LTM3S2xNdkJoZjhDUWZhUGhPV2JubjRTaVNDUDRmVUMzeExOUFJTQ1E4RWZHaENoU1k5cmM?oc=5" target="_blank"&gt;카나프테라퓨틱스, 황반변성 치료물질 'KNP-301' 전임상 결과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;청년의사&lt;/font&gt;</description><source url="http://www.docdocdoc.co.kr">청년의사</source></item><item><title>대원제약, ADA 2026서 4중 작용 비만치료제 전임상 성과 공개 - 한국식품의약신문</title><link>https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9CR3NBQl9YaGpxWlZreVAzd1YtdkpRdllaT1hybDZRc0RmeG5rUlNzRFZlVUN5eXIxV1RhaWJVLU1MNzY1M3pPQjQ0SnNfX3RaaWo0aHJ2VXNuYWVTdWRnZFZDUVYwcTA?oc=5</link><guid isPermaLink="false">CBMiZ0FVX3lxTE9CR3NBQl9YaGpxWlZreVAzd1YtdkpRdllaT1hybDZRc0RmeG5rUlNzRFZlVUN5eXIxV1RhaWJVLU1MNzY1M3pPQjQ0SnNfX3RaaWo0aHJ2VXNuYWVTdWRnZFZDUVYwcTA</guid><pubDate>Thu, 04 Jun 2026 06:08:13 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZ0FVX3lxTE9CR3NBQl9YaGpxWlZreVAzd1YtdkpRdllaT1hybDZRc0RmeG5rUlNzRFZlVUN5eXIxV1RhaWJVLU1MNzY1M3pPQjQ0SnNfX3RaaWo0aHJ2VXNuYWVTdWRnZFZDUVYwcTA?oc=5" target="_blank"&gt;대원제약, ADA 2026서 4중 작용 비만치료제 전임상 성과 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;한국식품의약신문&lt;/font&gt;</description><source url="https://www.kfmn.co.kr">한국식품의약신문</source></item><item><title>대원제약, 4중 비만치료 후보물질 전임상서 체중 50% 감소 확인 - PRESS9</title><link>https://news.google.com/rss/articles/CBMiZkFVX3lxTFA1VWtueTY2Q2FBenI1bmVzdDVRM3BTSVJKM1gwQnluQTZSYzdpb1R0NjdLQXIybi0wdzZLNmhTelZ6c3EzMXlmMEd1a0JDUTA4anQxNFQxQ3R6ZlZIWWtrWW43LWgtQQ?oc=5</link><guid isPermaLink="false">CBMiZkFVX3lxTFA1VWtueTY2Q2FBenI1bmVzdDVRM3BTSVJKM1gwQnluQTZSYzdpb1R0NjdLQXIybi0wdzZLNmhTelZ6c3EzMXlmMEd1a0JDUTA4anQxNFQxQ3R6ZlZIWWtrWW43LWgtQQ</guid><pubDate>Thu, 04 Jun 2026 00:17:34 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiZkFVX3lxTFA1VWtueTY2Q2FBenI1bmVzdDVRM3BTSVJKM1gwQnluQTZSYzdpb1R0NjdLQXIybi0wdzZLNmhTelZ6c3EzMXlmMEd1a0JDUTA4anQxNFQxQ3R6ZlZIWWtrWW43LWgtQQ?oc=5" target="_blank"&gt;대원제약, 4중 비만치료 후보물질 전임상서 체중 50% 감소 확인&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;PRESS9&lt;/font&gt;</description><source url="https://www.press9.kr">PRESS9</source></item><item><title>대원제약, 4중 비만치료제 전임상 발표…“체중 50% 감소 확인” - 쿠키메디</title><link>https://news.google.com/rss/articles/CBMiY0FVX3lxTFBqOFpTeC1IeFZieEtud2F5RERrS3FaZTJBSXlXQ0JWYUV1UGRlNWFCYU85bEk3d2RWcldBLXl6NHQwZUg3aUtjSjh6ZlRBb3NNbWZiNjhzN1pQM0pXRUhYWVhJMA?oc=5</link><guid isPermaLink="false">CBMiY0FVX3lxTFBqOFpTeC1IeFZieEtud2F5RERrS3FaZTJBSXlXQ0JWYUV1UGRlNWFCYU85bEk3d2RWcldBLXl6NHQwZUg3aUtjSjh6ZlRBb3NNbWZiNjhzN1pQM0pXRUhYWVhJMA</guid><pubDate>Thu, 04 Jun 2026 02:41:45 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiY0FVX3lxTFBqOFpTeC1IeFZieEtud2F5RERrS3FaZTJBSXlXQ0JWYUV1UGRlNWFCYU85bEk3d2RWcldBLXl6NHQwZUg3aUtjSjh6ZlRBb3NNbWZiNjhzN1pQM0pXRUhYWVhJMA?oc=5" target="_blank"&gt;대원제약, 4중 비만치료제 전임상 발표…“체중 50% 감소 확인”&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;쿠키메디&lt;/font&gt;</description><source url="http://www.kukimedi.com">쿠키메디</source></item><item><title>지투지바이오, ADA서 차세대 비만치료제 전임상 데이터 공개 - 메디컬투데이</title><link>https://news.google.com/rss/articles/CBMiYkFVX3lxTFBRSVRzckdITS15djdDSmt6NWNBYk85TnF6cHJvR0VfajduNmdSOTFFSWhwdVJmMlZ5RHZIcTVsdTVxLXVlMlJaX3ByREhCT0xTYjdLbUNGd0JlRGg5RHhpMjN30gFsQVVfeXFMTXdHemhzc3Y1SWtTa1ZhY1djV0l0Uk82Z2dhYWR6RmhNcTR6R3I1WnY5TUFMMzVNNkRZbXVESGpXWUFqMU5MTDFtdnJOZmo4UDc2ZzJKUEJuMlF3OEcyeDF3MXNyTjRQTUl4U0E3?oc=5</link><guid isPermaLink="false">CBMiYkFVX3lxTFBRSVRzckdITS15djdDSmt6NWNBYk85TnF6cHJvR0VfajduNmdSOTFFSWhwdVJmMlZ5RHZIcTVsdTVxLXVlMlJaX3ByREhCT0xTYjdLbUNGd0JlRGg5RHhpMjN30gFsQVVfeXFMTXdHemhzc3Y1SWtTa1ZhY1djV0l0Uk82Z2dhYWR6RmhNcTR6R3I1WnY5TUFMMzVNNkRZbXVESGpXWUFqMU5MTDFtdnJOZmo4UDc2ZzJKUEJuMlF3OEcyeDF3MXNyTjRQTUl4U0E3</guid><pubDate>Mon, 08 Jun 2026 04:01:42 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiYkFVX3lxTFBRSVRzckdITS15djdDSmt6NWNBYk85TnF6cHJvR0VfajduNmdSOTFFSWhwdVJmMlZ5RHZIcTVsdTVxLXVlMlJaX3ByREhCT0xTYjdLbUNGd0JlRGg5RHhpMjN30gFsQVVfeXFMTXdHemhzc3Y1SWtTa1ZhY1djV0l0Uk82Z2dhYWR6RmhNcTR6R3I1WnY5TUFMMzVNNkRZbXVESGpXWUFqMU5MTDFtdnJOZmo4UDc2ZzJKUEJuMlF3OEcyeDF3MXNyTjRQTUl4U0E3?oc=5" target="_blank"&gt;지투지바이오, ADA서 차세대 비만치료제 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;메디컬투데이&lt;/font&gt;</description><source url="https://www.mdtoday.co.kr">메디컬투데이</source></item><item><title>와이바이오로직스, ‘전임상 딜’ 흐름 올라타나…하반기 중개연구 데이터 ‘주목’ - 더바이오</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTFB5TG42OFROZDhScDVQRnVpMUd3LTVSdEhmWTVoUTZxTHVRVlE4SGZVOEk4NGk2UXp1ZjBtbFNVN3FIWVA5eDh6eE4tOGJNZTdGXzNSbjh1WEVSMFFxemI5ZWhyejREcUxfbXdtd9IBcEFVX3lxTE5zY3FKbGVVVGxlc2pCY3AwOHhRYzNVLWFzV3o0RGtZQm9BZ2pmV0lkcmRBcEk4Y0hPRGl4UjJxSnQ1aHFidHdKMGZnOTdJVTFQaDY1TlNocWNBdjRBcWNqTG9NYm9JRk5iZVFJM0NlUVo?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTFB5TG42OFROZDhScDVQRnVpMUd3LTVSdEhmWTVoUTZxTHVRVlE4SGZVOEk4NGk2UXp1ZjBtbFNVN3FIWVA5eDh6eE4tOGJNZTdGXzNSbjh1WEVSMFFxemI5ZWhyejREcUxfbXdtd9IBcEFVX3lxTE5zY3FKbGVVVGxlc2pCY3AwOHhRYzNVLWFzV3o0RGtZQm9BZ2pmV0lkcmRBcEk4Y0hPRGl4UjJxSnQ1aHFidHdKMGZnOTdJVTFQaDY1TlNocWNBdjRBcWNqTG9NYm9JRk5iZVFJM0NlUVo</guid><pubDate>Sun, 31 May 2026 21:25:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTFB5TG42OFROZDhScDVQRnVpMUd3LTVSdEhmWTVoUTZxTHVRVlE4SGZVOEk4NGk2UXp1ZjBtbFNVN3FIWVA5eDh6eE4tOGJNZTdGXzNSbjh1WEVSMFFxemI5ZWhyejREcUxfbXdtd9IBcEFVX3lxTE5zY3FKbGVVVGxlc2pCY3AwOHhRYzNVLWFzV3o0RGtZQm9BZ2pmV0lkcmRBcEk4Y0hPRGl4UjJxSnQ1aHFidHdKMGZnOTdJVTFQaDY1TlNocWNBdjRBcWNqTG9NYm9JRk5iZVFJM0NlUVo?oc=5" target="_blank"&gt;와이바이오로직스, ‘전임상 딜’ 흐름 올라타나…하반기 중개연구 데이터 ‘주목’&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;더바이오&lt;/font&gt;</description><source url="https://www.thebionews.net">더바이오</source></item><item><title>[BioS]대원제약, ADA서 비만 '4중 작용제' 전임상 결과 "공개" - 이투데이</title><link>https://news.google.com/rss/articles/CBMiVEFVX3lxTE9rUkh2elFldUluQ2ktSUZTY1lpbkZfM0MtSU1abi1zMjgwc01tZHo3Z1Y1MngtaHlCTHhoc05HZmlKbXNfbUVEek05b2IwajhrV2oySA?oc=5</link><guid isPermaLink="false">CBMiVEFVX3lxTE9rUkh2elFldUluQ2ktSUZTY1lpbkZfM0MtSU1abi1zMjgwc01tZHo3Z1Y1MngtaHlCTHhoc05HZmlKbXNfbUVEek05b2IwajhrV2oySA</guid><pubDate>Thu, 04 Jun 2026 02:15:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTE9rUkh2elFldUluQ2ktSUZTY1lpbkZfM0MtSU1abi1zMjgwc01tZHo3Z1Y1MngtaHlCTHhoc05HZmlKbXNfbUVEek05b2IwajhrV2oySA?oc=5" target="_blank"&gt;[BioS]대원제약, ADA서 비만 '4중 작용제' 전임상 결과 "공개"&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;이투데이&lt;/font&gt;</description><source url="https://www.etoday.co.kr">이투데이</source></item><item><title>[바이오스냅] 코오롱생명과학, 항암제 KLS-3021 전임상 결과 발표 - 연합뉴스</title><link>https://news.google.com/rss/articles/CBMiW0FVX3lxTE9qNzVwcTBuTEdLSktCU0twd2ZpdXRfT0tJTFc5Z1BoNWtIYlBoV3FsYy1nSGZTejh3dHh1QklVNVd5dURqanRpRnpUeVI0UU1maUVhZVBjUWdSYWfSAWBBVV95cUxOZlZoVEdVUzZGYzVSRzVZeUhUR0lVRkxjZjVTS1hUYjlocFpJOHBGbDJiOTlUODl5MVR6WEkxV0h3VVMzR2VBSk5CMVdwRkhYZ2t0dHJFWUNnWEpoTWl4Rnc?oc=5</link><guid isPermaLink="false">CBMiW0FVX3lxTE9qNzVwcTBuTEdLSktCU0twd2ZpdXRfT0tJTFc5Z1BoNWtIYlBoV3FsYy1nSGZTejh3dHh1QklVNVd5dURqanRpRnpUeVI0UU1maUVhZVBjUWdSYWfSAWBBVV95cUxOZlZoVEdVUzZGYzVSRzVZeUhUR0lVRkxjZjVTS1hUYjlocFpJOHBGbDJiOTlUODl5MVR6WEkxV0h3VVMzR2VBSk5CMVdwRkhYZ2t0dHJFWUNnWEpoTWl4Rnc</guid><pubDate>Mon, 18 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE9qNzVwcTBuTEdLSktCU0twd2ZpdXRfT0tJTFc5Z1BoNWtIYlBoV3FsYy1nSGZTejh3dHh1QklVNVd5dURqanRpRnpUeVI0UU1maUVhZVBjUWdSYWfSAWBBVV95cUxOZlZoVEdVUzZGYzVSRzVZeUhUR0lVRkxjZjVTS1hUYjlocFpJOHBGbDJiOTlUODl5MVR6WEkxV0h3VVMzR2VBSk5CMVdwRkhYZ2t0dHJFWUNnWEpoTWl4Rnc?oc=5" target="_blank"&gt;[바이오스냅] 코오롱생명과학, 항암제 KLS-3021 전임상 결과 발표&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;연합뉴스&lt;/font&gt;</description><source url="https://www.yna.co.kr">연합뉴스</source></item><item><title>HEM파마, COPD 신약 후보균주 'HEM20792' 전임상 결과 네이처 자매지 게재 - 약사공론</title><link>https://news.google.com/rss/articles/CBMibEFVX3lxTE5HeWE0TUVta1ByZXJmX2RuVHh1SlU2NWhnVHFYZUlrNXQyQjB3R2ZKUkF5a0R5RFIwaGQ1eFhsMmlma3ZieVYwdDM1a1lEVE05YUtjMXJ5czBLeFVEX1kyRjUzMER4VUd0SEdJeQ?oc=5</link><guid isPermaLink="false">CBMibEFVX3lxTE5HeWE0TUVta1ByZXJmX2RuVHh1SlU2NWhnVHFYZUlrNXQyQjB3R2ZKUkF5a0R5RFIwaGQ1eFhsMmlma3ZieVYwdDM1a1lEVE05YUtjMXJ5czBLeFVEX1kyRjUzMER4VUd0SEdJeQ</guid><pubDate>Mon, 11 May 2026 07:00:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE5HeWE0TUVta1ByZXJmX2RuVHh1SlU2NWhnVHFYZUlrNXQyQjB3R2ZKUkF5a0R5RFIwaGQ1eFhsMmlma3ZieVYwdDM1a1lEVE05YUtjMXJ5czBLeFVEX1kyRjUzMER4VUd0SEdJeQ?oc=5" target="_blank"&gt;HEM파마, COPD 신약 후보균주 'HEM20792' 전임상 결과 네이처 자매지 게재&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;약사공론&lt;/font&gt;</description><source url="https://www.kpanews.co.kr">약사공론</source></item><item><title>프로티나, ADA 2026서 차세대 비만 치료제 전임상 데이터 공개 - 네이트</title><link>https://news.google.com/rss/articles/CBMiU0FVX3lxTE42UUNOcnlLYkhhUGx2VEhHNXJuZl9PejBCMWduX1lSeW9WZ3VjM2FtMk1EaDlMVjl3SjAzSnRSdDgxNWlzUWJfWUNYVFRJclV6TDg4?oc=5</link><guid isPermaLink="false">CBMiU0FVX3lxTE42UUNOcnlLYkhhUGx2VEhHNXJuZl9PejBCMWduX1lSeW9WZ3VjM2FtMk1EaDlMVjl3SjAzSnRSdDgxNWlzUWJfWUNYVFRJclV6TDg4</guid><pubDate>Tue, 09 Jun 2026 01:22:00 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiU0FVX3lxTE42UUNOcnlLYkhhUGx2VEhHNXJuZl9PejBCMWduX1lSeW9WZ3VjM2FtMk1EaDlMVjl3SjAzSnRSdDgxNWlzUWJfWUNYVFRJclV6TDg4?oc=5" target="_blank"&gt;프로티나, ADA 2026서 차세대 비만 치료제 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;네이트&lt;/font&gt;</description><source url="https://news.nate.com">네이트</source></item><item><title>지투지바이오, ADA서 '이중·삼중 작용제' 전임상 데이터 공개 - 금강일보</title><link>https://news.google.com/rss/articles/CBMiakFVX3lxTE95Nl9VeG9ud2lsZXBCOFlDWlp2bUptbTQxNkZIM184WlVSM09qbW5xTjg4T3RiZlVBNHhNR0VQb2J0ZTFXTHhZcTFqZVJHLVB3LVd6S3dCMlVaOUtjUzl6R0drTlJlM3lnVGc?oc=5</link><guid isPermaLink="false">CBMiakFVX3lxTE95Nl9VeG9ud2lsZXBCOFlDWlp2bUptbTQxNkZIM184WlVSM09qbW5xTjg4T3RiZlVBNHhNR0VQb2J0ZTFXTHhZcTFqZVJHLVB3LVd6S3dCMlVaOUtjUzl6R0drTlJlM3lnVGc</guid><pubDate>Mon, 08 Jun 2026 03:36:21 GMT</pubDate><description>&lt;a href="https://news.google.com/rss/articles/CBMiakFVX3lxTE95Nl9VeG9ud2lsZXBCOFlDWlp2bUptbTQxNkZIM184WlVSM09qbW5xTjg4T3RiZlVBNHhNR0VQb2J0ZTFXTHhZcTFqZVJHLVB3LVd6S3dCMlVaOUtjUzl6R0drTlJlM3lnVGc?oc=5" target="_blank"&gt;지투지바이오, ADA서 '이중·삼중 작용제' 전임상 데이터 공개&lt;/a&gt;&amp;nbsp;&amp;nbsp;&lt;font color="#6f6f6f"&gt;금강일보&lt;/font&gt;</description><source url="https://www.ggilbo.com">금강일보</source></item></channel></rss>